<!DOCTYPE html SYSTEM "about:legacy-compat">
<html lang="en-US" class="no-js">
  <head>
    <meta charset="utf-8"/>
    <title>Chapter 69 Maryland Medicaid Managed Care Program: Rare and Expensive Case Management | Library of Maryland Regulations</title>
    <link rel="shortcut icon" href="/us/md/exec/_document/v2/images/favicons/favicon.ico"/>
    <!--Meta-->
    <meta http-equiv="X-UA-Compatible" content="IE=EDGE"/>
    <meta name="viewport" content="width=device-width, initial-scale=1"/>
    <meta name="format-detection" content="telephone=no"/>
    <meta name="HandheldFriendly" content="true"/>
    <meta itemprop="full-html" content="/us/md/exec/comar/10.09.69/index.full.html" data-document="href"/>
    <meta itemprop="toc-json" content="/us/md/exec/comar/10.09.69/index.json" data-document="href"/>
    <meta itemprop="parent-doc-url" content="/us/md/exec/comar" data-document="href"/>
    <meta itemprop="order" content="|10|09|69|"/>
    <meta itemprop="doc-type" content="container" data-document=""/>
    <meta itemprop="doc-num" content="69"/>
    <meta itemprop="ref-doc" content="Code of Maryland Regulations" data-document=""/>
    <meta itemprop="ref-path" content="10|09|69" data-document=""/>
    <!--OpenGraph-->
    <meta property="og:url" content="http://regs.maryland.gov//us/md/exec/comar/10.09.69"/>
    <meta property="og:type" content="article"/>
    <meta property="og:title" content="Chapter 69 Maryland Medicaid Managed Care Program: Rare and Expensive Case Management | Library of Maryland Regulations"/>
    <meta property="og:image" content="http://regs.maryland.gov//us/md/exec/_document/v2/images/og/og_image.png"/>
    <!--Progressive Web App-->
    <link rel="manifest" href="/manifest.json"/>
    <meta name="apple-mobile-web-app-capable" content="yes"/>
    <meta name="apple-mobile-web-app-status-bar-style" content="#0078EF"/>
    <meta name="apple-mobile-web-app-title" content="Library of Maryland Regulations"/>
    <meta name="theme-color" content="#0078EF"/>
    <meta name="apple-mobile-web-app-capable" content="yes"/>
    <meta name="mobile-web-app-capable" content="yes"/>
    <!--PWA icons-->
    <link rel="apple-touch-icon" sizes="180x180" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="60x60" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-60x60-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="76x76" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-76x76-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="152x152" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-152x152-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="180x180" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-180x180-precomposed.png"/>
    <link rel="mask-icon" href="/us/md/exec/_document/v2/images/favicons/safari-pinned-tab.svg" color="#0078EF"/>
    <link rel="icon" type="image/png" sizes="16x16" href="/us/md/exec/_document/v2/images/favicons/favicon-16x16.png"/>
    <link rel="icon" type="image/png" sizes="32x32" href="/us/md/exec/_document/v2/images/favicons/favicon-32x32.png"/>
    <link rel="icon" type="image/png" sizes="48x48" href="/us/md/exec/_document/v2/images/favicons/favicon-48x48.png"/>
    <!--Fonts-->
    <link href="/us/md/exec/_document/v2/biticons/biticons.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/public-sans/public-sans.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/merriweather/merriweather.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/roboto-mono/roboto-mono.css" type="text/css" rel="stylesheet" data-document=""/>
    <!--Document CSS-->
    <link href="/us/md/exec/_document/v2/styles/responsive.min.css" type="text/css" rel="stylesheet" media="screen" data-document=""/>
    <link href="/us/md/exec/_document/v2/styles/main.min.css" type="text/css" rel="stylesheet" media="screen" data-document=""/>
    <link href="/us/md/exec/_document/v2/styles/print.min.css" type="text/css" rel="stylesheet" media="print" data-document=""/>
    <link href="/_reader/styles/main.min.css" type="text/css" rel="stylesheet"/>
    <script src="/_reader/js/main.js" data-document=""> </script>
    <!--Links to resources that need to be prefetched-->
    <link rel="prefetch" href="/us/md/exec/comar/10.09.69/index.full.html" as="fetch"/>
    <link rel="prefetch" href="/index.json" as="fetch"/>
    <link rel="prefetch" href="/us/md/exec/comar/10.09.69/index.json" as="fetch"/>
  </head>
  <body>
    <div role="region" id="announcer" aria-live="polite" class="sr-only" aria-atomic="true" aria-label="Live messages">
      <p id="message"> </p>
    </div>
    <nav class="visually-hidden">
      <a href="#area__content" class="skip-link">Skip to main content</a>
    </nav>
    <div id="grid" class="ns__document__maryland-dsd">
      <header id="section__header" class="ns__document__maryland-dsd">
        <div id="section__header__inner" class="ns__document__maryland-dsd">
          <div id="area__logo" class="ns__document__maryland-dsd">
            <a href="/" class="logo" aria-label="Logo - Return to library home page">
              <img src="/us/md/exec/_document/v2/images/logo/logo.png" srcset="/us/md/exec/_document/v2/images/logo/logo.png 1x, /us/md/exec/_document/v2/images/logo/logo@2x.png 2x, /us/md/exec/_document/v2/images/logo/logo@3x.png 3x" alt="Library of Maryland Regulations logo"/>
            </a>
          </div>
          <div id="area__main_title" class="ns__document__maryland-dsd">
            <div class="h__library-logotype"><span class="line1">Library of</span> <span class="line2">Maryland Regulations</span></div>
          </div>
        </div>
      </header>
      <div id="section__content" class="ns__document__maryland-dsd">
        <div id="section__content__inner" class="ns__document__maryland-dsd">
          <section id="area__breadcrumbs" class="ns__document__maryland-dsd" role="region" aria-label="Breadcrumbs">
            <input type="checkbox" id="menu-trigger" class="menu-trigger" aria-label="Mobile menu toggler"/>
            <label for="menu-trigger">
              <span class="visually-hidden">Toggle mobile menu</span>
            </label>
            <nav role="navigation" aria-label="Breadcrumb navigation">
              <div class="h__ui">Navigation</div>
              <ul class="ancestors">
                <li data-search-path="library" data-search-heading="All Documents" class="no-indent">
                  <a href="/" title="Library of Maryland Regulations">Library of Maryland Regulations</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations" data-search-heading="" data-search-default="true" class="li__book-open">
                  <a href="/us/md/exec/comar" title="Code of Maryland Regulations">Code of Maryland Regulations</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|10" data-search-heading="">
                  <a href="/us/md/exec/comar/10" title="Title 10 MARYLAND DEPARTMENT OF HEALTH">Title 10 MARYLAND DEPARTMENT OF HEALTH</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|10|09" data-search-heading="">
                  <a href="/us/md/exec/comar/10.09" title="Subtitle 09 MEDICAL CARE PROGRAMS">Subtitle 09 MEDICAL CARE PROGRAMS</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|10|09|69" data-search-heading="">
                  <span title="Chapter 69 Maryland Medicaid Managed Care Program: Rare and Expensive Case Management">Chapter 69 Maryland Medicaid Managed Care Program: Rare and Expensive Case Management</span>
                </li>
              </ul>
            </nav>
          </section>
          <main id="area__content" class="ns__document__maryland-dsd">
            <div class="h__document-title">Code of Maryland Regulations</div>
            <article class="content" role="document" data-ref-path="10|09|69">
              <div class="tuf-authenticate">
                <h1 class="h__title--small" id="/us/md/exec/comar/10.09.69">Chapter 69 Maryland Medicaid Managed Care Program: Rare and Expensive Case Management</h1>
                <section class="line-group annotations">
                  <h2>Administrative History</h2>
                  <p>Effective date:</p>
                  <p>Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.69.01" title=".01 Purpose.">.01</a>—<a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.69.17" title=".17 Table of Rare and Expensive Disease Diagnosis.">.17</a> adopted as an emergency provision effective November 8, 1996 (23:25 Md. R. 1730)</p>
                  <p>Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.69.01" title=".01 Purpose.">.01</a>—<a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.69.17" title=".17 Table of Rare and Expensive Disease Diagnosis.">.17</a> adopted effective March 10, 1997 (24:5 Md. R. 408)</p>
                  <p>Regulations .01, .02, .05, .06, .08—.11, and .13 amended as an emergency provision effective July 1, 1997 (24:16 Md. R. 1151); emergency status expired December 31, 1997</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.69.01" title=".01 Purpose.">Regulation .01</a> amended effective February 9, 1998 (25:3 Md. R. 144)</p>
                  <p>Regulations .01, .02, and .14 amended as an emergency provision effective July 1, 1998 (25:16 Md. R. 1261)</p>
                  <p>Regulations .01, .02, .09, .10, and .14 amended effective January 1, 1999 (25:26 Md. R. 1925)</p>
                  <p>Regulation .01O amended effective October 16, 2000 (27:20 Md. R. 1839)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.69.02" title=".02 Definitions.">Regulation .02</a> amended effective February 9, 1998 (25:3 Md. R. 144)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.69.02" title=".02 Definitions.">Regulation .02</a> repealed as an emergency provision effective December 1, 2000 (27:26 Md. R. 2355); emergency status extended at 28:7 Md. R. 685; repealed permanently effective June 25, 2001 (28:12 Md. R. 1109)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.69.03" title=".03 REM Eligibility.">Regulation .03</a> amended as an emergency provision effective December 1, 2000 (27:26 Md. R. 2355); emergency status extended at 28:7 Md. R. 685; amended permanently effective June 25, 2001 (28:12 Md. R. 1109)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.69.04" title=".04 Participant Enrollment and Disenrollment.">Regulation .04</a> amended as an emergency provision effective December 1, 2000 (27:26 Md. R. 2355); emergency status extended at 28:7 Md. R. 685; amended permanently effective June 25, 2001 (28:12 Md. R. 1109)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.69.05" title=".05 Benefits.">Regulation .05</a> amended effective February 9, 1998 (25:3 Md. R. 144)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.69.05" title=".05 Benefits.">Regulation .05</a> amended as an emergency provision effective December 1, 2000 (27:26 Md. R. 2355); emergency status extended at 28:7 Md. R. 685; amended permanently effective June 25, 2001 (28:12 Md. R. 1109)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.69.06#B" title="">Regulation .06B</a> amended effective February 9, 1998 (25:3 Md. R. 144)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.69.08" title=".08 Specific Conditions for Provider Participation.">Regulation .08</a> amended effective February 9, 1998 (25:3 Md. R. 144)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.69.09#B" title="">Regulation .09B</a> amended effective February 9, 1998 (25:3 Md. R. 144)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.69.10#B" title="">Regulation .10B</a> amended effective February 9, 1998 (25:3 Md. R. 144)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.69.11#B" title="">Regulation .11B</a> amended effective February 9, 1998 (25:3 Md. R. 144)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.69.13#B" title="">Regulation .13B</a> amended effective February 9, 1998 (25:3 Md. R. 144)</p>
                  <p>——————</p>
                  <p>Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.69.01" title=".01 Purpose.">.01</a>—<a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.69.17" title=".17 Table of Rare and Expensive Disease Diagnosis.">.17</a> repealed and new Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.69.01" title=".01 Purpose.">.01</a>—<a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.69.17" title=".17 Table of Rare and Expensive Disease Diagnosis.">.17</a> adopted effective February 2, 2004 (31:2 Md. R. 84)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.69.02#B" title="">Regulation .02B</a> amended effective November 6, 2006 (33:22 Md. R. 1732)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.69.04" title=".04 Participant Enrollment and Disenrollment.">Regulation .04</a> amended effective December 24, 2012 (39:25 Md. R. 1613)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.69.05#B" title="">Regulation .05B</a>, C amended effective November 6, 2006 (33:22 Md. R. 1732)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.69.05#C" title="">Regulation .05C</a>, D amended effective October 5, 2009 (36:20 Md. R. 1528)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.69.07#G" title="">Regulation .07G</a> amended effective November 6, 2006 (33:22 Md. R. 1732)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.69.09" title=".09 Covered Services — General Requirements.">Regulation .09</a> amended effective November 6, 2006 (33:22 Md. R. 1732)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.69.12#B" title="">Regulation .12B</a> amended effective November 5, 2007 (34:22 Md. R. 1977)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.69.12#C" title="">Regulation .12C</a> amended effective November 6, 2006 (33:22 Md. R. 1732)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.69.13#B" title="">Regulation .13B</a>, C amended effective November 6, 2006 (33:22 Md. R. 1732)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.69.13#C" title="">Regulation .13C</a> amended effective October 14, 2013 (40:20 Md. R. 1652)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.69.14#E" title="">Regulation .14E</a>, F, G adopted effective October 5, 2009 (36:20 Md. R. 1528)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.69.14#E" title="">Regulation .14E</a> amended effective April 4, 2011 (38:7 Md. R. 431)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.69.17" title=".17 Table of Rare and Expensive Disease Diagnosis.">Regulation .17</a> amended effective November 5, 2007 (34:22 Md. R. 1977); June 30, 2008 (35:13 Md. R. 1180); October 5, 2009 (36:20 Md. R. 1528); December 27, 2010 (37:26 Md. R. 1787); December 24, 2012 (39:25 Md. R. 1613)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.69.17" title=".17 Table of Rare and Expensive Disease Diagnosis.">Regulation .17</a> repealed and new Regulation .17 adopted effective October 26, 2015 (42:21 Md. R. 1301)</p>
                  <p>——————</p>
                  <p>Chapter revised effective July 2, 2018 (45:13 Md. R. 665)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.69.02#B" title="">Regulation .02B</a> amended effective June 24, 2024 (51:12 Md. R. 619)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.69.04#F" title="">Regulation .04F</a> amended effective May 20, 2019 (46:10 Md. R. 486)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.69.04#K" title="">Regulation .04K</a>, L adopted effective November 23, 2023 (50:23 Md. R. 1005)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.69.11#A" title="">Regulation .11A</a> amended effective June 24, 2024 (51:12 Md. R. 619)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.69.12" title=".12 Limitations.">Regulation .12</a> amended effective June 24, 2024 (51:12 Md. R. 619)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.69.14" title=".14 Payment Procedures — Request for Payment.">Regulation .14</a> amended effective November 14, 2022 (49:23 Md. R. 996); November 23, 2023 (50:23 Md. R. 1005)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.69.14#D" title="">Regulation .14D</a>, E amended effective May 20, 2019 (46:10 Md. R. 486); November 18, 2019 (46:23 Md. R. 1065)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.69.17" title=".17 Table of Rare and Expensive Disease Diagnosis.">Regulation .17</a> amended effective May 20, 2019 (46:10 Md. R. 486); November 14, 2022 (49:23 Md. R. 996)​; November 23, 2023 (50:23 Md. R. 1005)</p>
                  <h2>Authority</h2>
                  <p>Health-General Article, §§2-104(b), 15-103(b)(4)(i), and 15-105, Annotated Code of Maryland</p>
                </section>
                <h2 id="/us/md/exec/comar/10.09.69.01" data-order="|10|09|69|.01|" data-ref-path="10|09|69|.01" class="h__section">.01 Purpose.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.69.01#A">A.</span> The purpose of the Rare and Expensive Case Management (REM) program is to provide case management services and subspecialty care for Maryland Medicaid Managed Care Program eligible individuals with rare and expensive conditions.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.69.01#B">B.</span> The program is designed to provide Maryland Medicaid Managed Care Program eligible individuals diagnosed with qualifying rare and expensive conditions the following benefits when the individual elects to participate in the program:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.01#B(1)">(1)</span> Case management services; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.01#B(2)">(2)</span> REM optional services.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.09.69.02" data-order="|10|09|69|.02|" data-ref-path="10|09|69|.02" class="h__section">.02 Definitions.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#A">A.</span> In this chapter, the following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(1)">(1)</span> “Activities of daily living” means tasks or activities that include but are not limited to bathing, feeding, toileting, dressing, and ambulation.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(2)">(2)</span> “Business day” means any day except Saturday, Sunday, or a holiday on which State offices are closed.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(3)">(3)</span> “Caregiver” means a willing and able individual who is trained in providing care to the participant.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(4)">(4)</span> “Case management” means assessing, planning, coordinating, and monitoring the delivery of medically necessary health-related services.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(5)">(5)</span> “Case management provider” means the Department's designee, or a subcontractor of the designee, which provides case management to participants assigned to it by the Department.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(6)">(6)</span> “Case manager” means, an individual who is:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(6)(a)">(a)</span> A social worker with active and nationally recognized certification in case management or an RN;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(6)(b)">(b)</span> Employed by the Department's designee; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(6)(c)">(c)</span> Assigned by the Department's designee to manage the care of some or all of the participants.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(7)">(7)</span> “Cause” means a significant change in medical condition such that it is no longer medically efficacious for the individual to remain in the MCO as determined by the Department.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(8)">(8)</span> “Certified medication technician (CMT)” means an individual who:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(8)(a)">(a)</span> Completes a 20-hour course in medication administration approved by the Maryland Board of Nursing;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(8)(b)">(b)</span> Is certified by the Maryland Board of Nursing under <a class="internal-link no-wrap" href="/us/md/exec/comar/10.39.04" title="Chapter 04 Medication Technicians">COMAR 10.39.04</a>; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(8)(c)">(c)</span> Performs medication administration tasks delegated by a nurse in accordance with <a class="internal-link no-wrap" href="/us/md/exec/comar/10.27.11" title="Chapter 11 Delegation of Nursing Functions">COMAR 10.27.11</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(9)">(9)</span> “Certified nursing assistant (CNA)” means an individual who:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(9)(a)">(a)</span> Is certified by the Maryland Board of Nursing under <a class="internal-link no-wrap" href="/us/md/exec/comar/10.39.05" title="Chapter 05 Standards of Practice for Certified Nursing Assistants (CNA)">COMAR 10.39.05</a>; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(9)(b)">(b)</span> Routinely performs nursing tasks delegated by a nurse in accordance with <a class="internal-link no-wrap" href="/us/md/exec/comar/10.27.11" title="Chapter 11 Delegation of Nursing Functions">COMAR 10.27.11</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(10)">(10)</span> “Certified nursing assistant certified as a CMT (CNA-CMT)” means an individual who:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(10)(a)">(a)</span> Is certified by the Maryland Board of Nursing under <a class="internal-link no-wrap" href="/us/md/exec/comar/10.39.05" title="Chapter 05 Standards of Practice for Certified Nursing Assistants (CNA)">COMAR 10.39.05</a> and <a class="internal-link no-wrap" href="/us/md/exec/comar/10.39.04" title="Chapter 04 Medication Technicians">10.39.04</a>;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(10)(b)">(b)</span> Completes a 20-hour course in medication administration approved by the Maryland Board of Nursing; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(10)(c)">(c)</span> Routinely performs nursing tasks including medication administration tasks delegated by a nurse in accordance with <a class="internal-link no-wrap" href="/us/md/exec/comar/10.27.11" title="Chapter 11 Delegation of Nursing Functions">COMAR 10.27.11</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(11)">(11)</span> “Chiropractor” means an individual who is licensed by the Maryland State Board of Chiropractic Examiners to practice chiropractic in Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(12)">(12)</span> “Delegated nursing services” means nursing services provided to a participant by a CNA, CNA-CMT, HHA, or HHA-CMT under the supervision of an RN in accordance with <a class="internal-link no-wrap" href="/us/md/exec/comar/10.27.11" title="Chapter 11 Delegation of Nursing Functions">COMAR 10.27.11</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(13)">(13)</span> “Dental service provider” means an individual who is licensed and legally authorized to practice dentistry in the state in which the service is provided.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(14)">(14)</span> “Department” means the Department of Health, as defined in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.36.01" title=".01 Definitions.">COMAR 10.09.36.01</a>, or its authorized agents acting on behalf of the Department.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(15)">(15)</span> “Dietitian-nutritionist” means an individual who is licensed as a dietitian-nutritionist by the Maryland State Board of Dietetic Practice to practice dietetics in Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(16)">(16)</span> “Early and periodic screening, diagnosis, and treatment (EPSDT)” means the provision, to individuals younger than 21 years old, of preventive health care pursuant to 42 CFR §441.50 et seq., as amended, and other health care services, diagnostic services, and treatment services that are necessary to correct or ameliorate defects, physical and mental illnesses, and conditions discovered by EPSDT screening services.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(17)">(17)</span> “EPSDT-certified provider” means a physician, physician assistant or nurse practitioner who is certified by the Department's EPSDT program to provide well-child services according to the Department's periodicity schedule and program standards to enrollees younger than 21 years old.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(18)">(18)</span> “EPSDT periodicity schedule” means the list approved by the Department of required or recommended preventive health care services for children and adolescents.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(19)">(19)</span> “EPSDT services” means:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(19)(a)">(a)</span> Screening services provided by an EPSDT-certified provider that are required or recommended on the EPSDT periodicity schedule; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(19)(b)">(b)</span> Health care services performed to diagnose, treat, or refer problems or conditions discovered during the comprehensive well-child service.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(20)">(20)</span> “Evaluation” means a determination of the health status of a patient in a patient's home or any other appropriate setting by a licensed professional for the purpose of designing an individual plan of care, which incorporates the modalities of treatment that will promote optimal functional ability and recuperation.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(21)">(21)</span> “Family member” means an adult who:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(21)(a)">(a)</span> Lives with or provides care to the participant; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(21)(b)">(b)</span> Is not paid to provide the care under the REM program.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(22)">(22)</span> “HealthChoice” means Maryland Medicaid's Statewide mandatory managed care program as defined in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04" title="Chapter 04 Maryland Medicaid Managed Care Program: Managed Care Organizations">COMAR 10.67.04</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(23)">(23)</span> “Home” means the place of residence, occupied by the participant, other than a residence or facility where nursing services are included in the living arrangement by regulation or statute, or otherwise provided for payment.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(24)">(24)</span> “Home health agency” means an agency licensed by the Department in accordance with <a class="internal-link no-wrap" href="/us/md/exec/comar/10.07.10" title="Chapter 10 Home Health Agencies">COMAR 10.07.10</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(25)">(25)</span> “Home health aide (HHA)” means an individual who meets all the conditions of participation specified in:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(25)(a)">(a)</span> 42 CFR §484.36; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(25)(b)">(b)</span> <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gho/gho.pdf" title="">Health Occupations Article, Title 8, Annotated Code of Maryland</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(26)">(26)</span> “Home health aide certified as a CMT (HHA-CMT)” means an individual who:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(26)(a)">(a)</span> Meets all the conditions of participation specified in 42 CFR §484.36 and <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gho/gho.pdf" title="">Health Occupations Article, Title 8, Annotated Code of Maryland</a>; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(26)(b)">(b)</span> Completes a 20-hour course in medication administration approved by the Maryland Board of Nursing.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(27)">(27)</span> “Hospital” means an institution licensed by and providing services in accordance with Health-General Article, §19-301, Annotated Code of Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(28)">(28)</span> “Individualized education program (IEP)” means a written description of special education and related services developed by an IEP team to be implemented to meet the individual needs of a child.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(29)">(29)</span> “Individualized family service plan (IFSP)” means a written plan for providing early intervention and other services to an eligible child and the child's family developed by an IFSP team.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(30)">(30)</span> “Interdisciplinary team" means the group comprised of the case manager and relevant service providers to develop the case management plan under the overall direction and coordination of the case manager, in consultation with the participant and, when applicable, the participant's family.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(31)">(31)</span> “Intermediate care facility for individuals with intellectual disabilities or individuals with related conditions (ICF-IID)” means an institution licensed by the Department under <a class="internal-link no-wrap" href="/us/md/exec/comar/10.07.20" title="Chapter 20 Intermediate Care Facilities for Individuals with Intellectual Disabilities or Persons with Related Conditions (ICF/IID)">COMAR 10.07.20</a> that provides health-related services or health rehabilitative services for individuals with intellectual disabilities or related conditions.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(32)">(32)</span> “Licensed practical nurse (LPN)” means an individual licensed to practice licensed practical nursing as defined in <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=8-301" title="">Health Occupations Article, §8-301, Annotated Code of Maryland</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(33)">(33)</span> “Managed care organization (MCO)” has the meaning stated in Health-General Article, §15-101, Annotated Code of Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(34)">(34)</span> “Medical Assistance” means the program administered by the State under Title XIX of the Social Security Act which provides comprehensive medical and other health-related care for categorically eligible and medically needy individuals.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(35)">(35)</span> “Medically necessary” means that the service or benefit is:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(35)(a)">(a)</span> Directly related to diagnostic, preventive, curative, palliative, rehabilitative, or ameliorative treatment of an illness, injury, disability, or health condition;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(35)(b)">(b)</span> Consistent with current accepted standards of good medical practice;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(35)(c)">(c)</span> The most cost-efficient service that can be provided without sacrificing effectiveness or access to care; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(35)(d)">(d)</span> Not primarily for the convenience of the participant, the participant's family, or the provider.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(36)">(36)</span> “Medicare” means the federal program that provides benefits to the aged and disabled under Title XVIII of the Social Security Act, 42 U.S.C. §1395 et seq.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(37)">(37)</span> “Nurse” means an individual who is licensed to practice as a registered nurse (RN) or a licensed practical nurse (LPN) in the jurisdiction in which services are provided.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(38)">(38)</span> “Nurse practitioner” means an individual who is licensed and certified to practice as a nurse practitioner in the jurisdiction in which services are provided.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(39)">(39)</span> “Nursing facility” has the meaning stated in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.10.01#B" title="">COMAR 10.09.10.01B</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(40)">(40)</span> “Nutritional counseling” means the assessment of the participant's nutritional status and education about improving their nutritional status provided by a licensed dietitian-nutritionist.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(41)">(41)</span> “Nutritional supplements” means enteral feeding which is medically indicated as either the sole source of nutrition or a supplement that enhances the physical well-being of the participant.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(42)">(42)</span> “Occupational therapist” means an individual licensed by the Maryland State Board of Occupational Therapy Practice to practice occupational therapy in Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(43)">(43)</span> “Participant” means an eligible individual who is enrolled in the Program.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(44)">(44)</span> “Physician” means an individual who is licensed or otherwise legally authorized to practice in the jurisdiction in which the services are rendered.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(45)">(45)</span> “Physician assistant” means an individual who is licensed to practice medicine with physician supervision as stated in the Health Occupations Article, §§<a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=15-301" title="">15-301</a>(d) and (e) and 15-302, Annotated Code of Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(46)">(46)</span> “Plan of care” means the document which governs a participant's care management which includes the:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(46)(a)">(a)</span> Case management assessment report;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(46)(b)">(b)</span> Interdisciplinary plan of care; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(46)(c)">(c)</span> Case management plan.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(47)">(47)</span> “Preauthorization” means the approval required from the Department or its designee before specific services may be rendered.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(48)">(48)</span> “Primary care provider (PCP)” means a physician, physician assistant, or nurse practitioner who is the primary coordinator of care for the participant, and whose responsibility it is to provide accessible, continuous, comprehensive, and coordinated health care services covering the full range of benefits required by the Maryland Medicaid Managed Care Program, as specified in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06" title="Chapter 06 Maryland Medicaid Managed Care Program: Benefits">COMAR 10.67.06</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(49)">(49)</span> “Private duty nursing” means skilled nursing services for participants, who require more individual and continuous care than is available under the home health program, which are provided by a registered nurse (RN) or a licensed practical nurse (LPN), in a participant's home or another setting when normal life activities take the participant outside his or her home.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(50)">(50)</span> “Program”, unless the context indicates otherwise, has the meaning stated in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.36.01#B" title="">COMAR 10.09.36.01B</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(51)">(51)</span> “Progress note” means a signed and dated written notation by the RN, LPN, CNA, CNA-CMT, HHA, or HHA-CMT, which:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(51)(a)">(a)</span> Summarizes facts about the care given and the participant's response during a given period of time;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(51)(b)">(b)</span> Specifically addresses the established goals of treatment;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(51)(c)">(c)</span> Is consistent with the participant's plan of care; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(51)(d)">(d)</span> Is written during the course of care.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(52)">(52)</span> “Provider” means an individual, agency, or facility, which is enrolled in the Program through an agreement with the Department, and has been identified as a Program provider by the issuance of a provider number.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(53)">(53)</span> “Rare and expensive case management (REM)” means a Maryland Medical Assistance program that provides case management services and optional services to eligible individuals with specific rare and expensive conditions.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(54)">(54)</span> “Rare and expensive condition” means a medical diagnosis or condition identified in <a class="internal-link " href="/us/md/exec/comar/10.09.69.16" title=".16 Cause for Suspension or Removal and Imposition of Sanctions.">Regulation .16 of this chapter</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(55)">(55)</span> “Registered nurse (RN)” means an individual licensed to practice registered nursing as defined in <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=8-301" title="">Health Occupations Article, §8-301, Annotated Code of Maryland</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(56)">(56)</span> “REM optional services” means the services listed in Regulations .10 and .11 of this chapter, which meet the general requirements under <a class="internal-link " href="/us/md/exec/comar/10.09.69.09" title=".09 Covered Services — General Requirements.">Regulation .09 of this chapter</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(57)">(57)</span> “Residential service agency” means an agency licensed by the Department in accordance with <a class="internal-link no-wrap" href="/us/md/exec/comar/10.07.05" title="Chapter 05 Residential Service Agencies">COMAR 10.07.05</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(58)">(58)</span> “Residential treatment center” means any institution which falls within the jurisdiction of Health-General Article, §19-308, Annotated Code of Maryland, and is licensed as required by <a class="internal-link no-wrap" href="/us/md/exec/comar/10.07.04" title="Chapter 04 Residential Treatment Centers for Emotionally Disturbed Children and Adolescents">COMAR 10.07.04</a> or other applicable standards established by the state in which the service is provided.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(59)">(59)</span> “School” means courses or classes for the acquisition of a General Education Diploma, a high school diploma, an associate degree, or a first-time bachelor’s degree.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(60)">(60)</span> “Social worker” means an individual who is licensed by the Maryland State Board of Social Work Examiners to practice social work in Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.02#B(61)">(61)</span> “Speech-language pathologist” means an individual who is licensed by the Maryland Board of Examiners for Audiologists, Hearing Aid Dispensers, and Speech-Language Pathologists to practice speech-language pathology in Maryland.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.09.69.03" data-order="|10|09|69|.03|" data-ref-path="10|09|69|.03" class="h__section">.03 REM Eligibility.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.69.03#A">A.</span> An individual is eligible to participate in the REM program if the individual:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.03#A(1)">(1)</span> Is eligible for Maryland Medicaid Managed Care as specified in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.02.01" title=".01 Eligibility.">COMAR 10.67.02.01</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.03#A(2)">(2)</span> Has one or more of the diagnoses specified in <a class="internal-link " href="/us/md/exec/comar/10.09.69.17" title=".17 Table of Rare and Expensive Disease Diagnosis.">Regulation .17 of this chapter</a>; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.03#A(3)">(3)</span> Elects to participate in the REM program.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.69.03#B">B.</span> The Department shall render a determination of an individual's eligibility within 5 business days on receipt of:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.03#B(1)">(1)</span> A completed REM application;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.03#B(2)">(2)</span> Any requested documentation verifying an individual meets the criteria set forth in <a class="internal-link " href="/us/md/exec/comar/10.09.69.03#A" title="">§A of this regulation</a>; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.03#B(3)">(3)</span> Verbal or written confirmation an individual elects to participate.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.09.69.04" data-order="|10|09|69|.04|" data-ref-path="10|09|69|.04" class="h__section">.04 Participant Enrollment and Disenrollment.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.69.04#A">A.</span> Anyone may refer an individual into the REM program including, but not limited to a:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.04#A(1)">(1)</span> Family member;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.04#A(2)">(2)</span> Physician;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.04#A(3)">(3)</span> Discharge planner;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.04#A(4)">(4)</span> Hospital;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.04#A(5)">(5)</span> Clinic;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.04#A(6)">(6)</span> Social worker; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.04#A(7)">(7)</span> Managed care organization (MCO).</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.69.04#B">B.</span> The Department shall enroll an individual determined eligible in the REM program when:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.04#B(1)">(1)</span> All pertinent documentation regarding needed medical services is received, reviewed, and approved;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.04#B(2)">(2)</span> Confirmation of the individual's election to participate in the program is received; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.04#B(3)">(3)</span> The individual is being discharged from an institution or transitioning from an MCO and service coordination is complete.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.69.04#C">C.</span> When an MCO participant is referred to the REM program for enrollment, the MCO shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.04#C(1)">(1)</span> Provide confirmation of the qualifying diagnosis to the Department; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.04#C(2)">(2)</span> Continue to provide the MCO participant's care until the Department confirms the diagnosis and enrolls the MCO participant into REM.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.69.04#D">D.</span> An individual shall be enrolled in or auto-assigned into an MCO as specified in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.02" title="Chapter 02 Maryland Medicaid Managed Care Program: Eligibility and Enrollment">COMAR 10.67.02</a>, not later than 60 days from the date the individual becomes ineligible for REM, as a result of changes in the diagnosis or age group criteria specified in <a class="internal-link " href="/us/md/exec/comar/10.09.69.17" title=".17 Table of Rare and Expensive Disease Diagnosis.">Regulation .17 of this chapter</a>, except when the individual was allowed to remain in REM in accordance with <a class="internal-link " href="/us/md/exec/comar/10.09.69.04#I" title="">§I of this regulation</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.69.04#E">E.</span> A REM participant may elect to disenroll from REM and enroll in an MCO by notifying the Department of that decision except when the individual was allowed to remain in REM in accordance with <a class="internal-link " href="/us/md/exec/comar/10.09.69.04#I" title="">§I of this regulation</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.69.04#F">F.</span> Election to Remain in MCO.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.04#F(1)">(1)</span> An individual who becomes eligible for REM while enrolled in an MCO may elect to remain in an MCO by notifying the Department of that decision.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.04#F(2)">(2)</span> When a REM-eligible individual elects to remain in an MCO, the Department, in consultation with the MCO and the REM-eligible individual, may determine whether the MCO can appropriately meet the individual's medical needs within the parameters of the program benefit package as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06" title="Chapter 06 Maryland Medicaid Managed Care Program: Benefits">COMAR 10.67.06</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.04#F(3)">(3)</span> If the MCO determines it cannot appropriately meet the individual's medical needs, the MCO shall submit to the Department written justification for its decision.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.04#F(4)">(4)</span> If the Department determines the MCO can meet the individual's medical needs, the Department shall notify the MCO of its decision in writing.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.04#F(5)">(5)</span> If the Department determines that the MCO cannot appropriately meet the individual's needs, the Department shall issue a written determination to the individual and the MCO which includes:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.69.04#F(5)(a)">(a)</span> The reason for the determination; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.69.04#F(5)(b)">(b)</span> An explanation of the individual's right to appeal the determination according to the procedures set forth in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.01.04" title="Chapter 04 Fair Hearing Appeals Under the Maryland State Medical Assistance Program">COMAR 10.01.04</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.04#F(6)">(6)</span> If the Department determines that the MCO can appropriately meet the individual's medical needs, the individual's election becomes effective and cannot be revoked without cause for a period of 1 year from the effective date.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.69.04#G">G.</span> The Department shall allow an individual who, immediately before enrollment in REM, was receiving medical services from a specialty clinic or other setting to continue to receive services in that setting on enrollment in the REM program when the provider is willing to participate as a Medical Assistance fee-for-service provider.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.69.04#H">H.</span> An individual eligible for REM who has elected to enroll in an MCO or to remain enrolled in an MCO may not receive REM services under the REM program.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.69.04#I">I.</span> The Department shall disenroll from the REM program a participant who no longer meets the conditions specified in <a class="internal-link " href="/us/md/exec/comar/10.09.69.03" title=".03 REM Eligibility.">Regulation .03 of this chapter</a> unless:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.04#I(1)">(1)</span> The participant does not meet the condition under <a class="internal-link " href="/us/md/exec/comar/10.09.69.03#A(1)" title="">Regulation .03A(1) of this chapter</a> because the participant becomes eligible for Medicare; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.04#I(2)">(2)</span> At the time the participant became eligible for Medicare the participant was approved for and was receiving private duty nursing, CNA, CNA-CMT, HHA, or HHA-CMT services under the REM program.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.69.04#J">J.</span> An individual disenrolled from REM by the Department who maintains HealthChoice eligibility is subject to the MCO enrollment provisions specified in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.02" title="Chapter 02 Maryland Medicaid Managed Care Program: Eligibility and Enrollment">COMAR 10.67.02</a> except when the individual was allowed to remain in REM in accordance with <a class="internal-link " href="/us/md/exec/comar/10.09.69.04#I" title="">§I of this regulation</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.69.04#K">K.</span> Department-Initiated Disenrollment. The Department shall disenroll from REM an enrollee:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.04#K(1)">(1)</span> Who has been continuously institutionalized for a period of more than 90 successive days in a long-term care facility, subject to the long-term care facility obtaining the Department’s determination that the enrollee’s institutionalization has been medically necessary;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.04#K(2)">(2)</span> Who has been, or is expected to be, continuously institutionalized for more than 30 successive days in an institution for mental disease (IMD);</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.04#K(3)">(3)</span> Upon admission to an intermediate care facility for individuals with intellectual disabilities or persons with related conditions (ICF/IID);</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.04#K(4)">(4)</span> Who loses Medicaid eligibility or who changes to an assistance category not eligible for MCO enrollment, subject to <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.02" title="Chapter 02 Maryland Medicaid Managed Care Program: Eligibility and Enrollment">COMAR 10.67.02</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.04#K(5)">(5)</span> Who has died; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.04#K(6)">(6)</span> Who is an inmate of a public institution, including a State-operated institution or facility.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.69.04#L">L.</span> Effective Date of Disenrollment. An enrollee’s disenrollment shall take effect:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.04#L(1)">(1)</span> Immediately when the enrollee dies;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.04#L(2)">(2)</span> From the first day of the month following the month in which the enrollee lost Medicaid eligibility;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.04#L(3)">(3)</span> On the first day of the month following the month in which the Department receives the required notification, when the enrollee permanently relocates outside of the State; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.04#L(4)">(4)</span> From the first day of the month following the month in which the Department verifies an enrollee is an inmate.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.09.69.05" data-order="|10|09|69|.05|" data-ref-path="10|09|69|.05" class="h__section">.05 Benefits.</h2>
                <p>A REM participant is eligible for the following:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.69.05#A">A.</span> Fee-for-service Medical Assistance benefits available to a Medical Assistance participant not enrolled in an MCO;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.69.05#B">B.</span> Services described in Regulations .10 and .11 of this chapter when determined medically necessary by the Department;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.69.05#C">C.</span> A case management assessment performed by a REM case manager who shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.05#C(1)">(1)</span> Gather all relevant information needed to determine the participant’s condition and needs including the participant’s medical records;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.05#C(2)">(2)</span> Consult with the participant's current service providers; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.05#C(3)">(3)</span> Evaluate the relevant information and complete a needs analysis including medical, psychosocial, environmental, and functional assessments; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.69.05#D">D.</span> Case management services performed by a REM case manager who shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.05#D(1)">(1)</span> When necessary, assist the REM participant, offering the participant a choice, if possible, in selecting and obtaining a PCP, who may be a specialist to the participant’s condition, giving preference to any pre-established relationships between the participant and the participant’s PCP;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.05#D(2)">(2)</span> Develop a plan of care in consultation with the participant, the participant's family members as authorized by the participant when possible, the PCP, and other providers rendering care that:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.69.05#D(2)(a)">(a)</span> Includes the participant's health status and needs for medical, health-related, housing, and social services including, but not limited to:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.09.69.05#D(2)(a)(i)">(i)</span> All pertinent diagnoses including the REM qualifying diagnosis;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.09.69.05#D(2)(a)(ii)">(ii)</span> Type, frequency, and duration of services;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.09.69.05#D(2)(a)(iii)">(iii)</span> Treatment goals for each type of service;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.09.69.05#D(2)(a)(iv)">(iv)</span> Medical equipment and supplies;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.09.69.05#D(2)(a)(v)">(v)</span> Medication;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.09.69.05#D(2)(a)(vi)">(vi)</span> Social support structure;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.09.69.05#D(2)(a)(vii)">(vii)</span> Current service providers;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.09.69.05#D(2)(a)(viii)">(viii)</span> Assigned level of care;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.09.69.05#D(2)(a)(ix)">(ix)</span> Nutritional status;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.09.69.05#D(2)(a)(x)">(x)</span> Education or vocational information;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.09.69.05#D(2)(a)(xi)">(xi)</span> Current living arrangement; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.09.69.05#D(2)(a)(xii)">(xii)</span> Emergency plan, if appropriate; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.69.05#D(2)(b)">(b)</span> Is developed in consultation with the interdisciplinary team;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.05#D(3)">(3)</span> Implement the plan of care and assist the participant in gaining access to medically necessary services by linking the participant to those services;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.05#D(4)">(4)</span> Monitor service delivery, perform record reviews, and maintain contacts with the participant, services providers, and family members to evaluate the participant's condition and progress and to determine whether revision is needed in the plan of care or in services' delivery;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.05#D(5)">(5)</span> As necessary, initiate and implement modifications to the plan of care and communicate these changes to the participant, parents or caregivers, and pertinent health care providers;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.05#D(6)">(6)</span> Monitor a participant's receipt of EPSDT services as specified in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06" title="Chapter 06 Maryland Medicaid Managed Care Program: Benefits">COMAR 10.67.06</a>; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.05#D(7)">(7)</span> Assist the participant with the coordination of school health-related services such as the IEP or the IFSP as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.50" title="Chapter 50 EPSDT School Health-Related Services or Health-Related Early Intervention Services">COMAR 10.09.50</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.09.69.06" data-order="|10|09|69|.06|" data-ref-path="10|09|69|.06" class="h__section">.06 Requirements for Provider Qualification.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.69.06#A">A.</span> A case manager providing case management under this chapter shall be:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.06#A(1)">(1)</span> An RN; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.06#A(2)">(2)</span> A social worker.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.69.06#B">B.</span> The following professionals providing services under this chapter to REM participants shall be licensed, certified, or otherwise legally authorized to practice in the jurisdiction in which the services are rendered:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.06#B(1)">(1)</span> Physicians;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.06#B(2)">(2)</span> Physician Assistants;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.06#B(3)">(3)</span> Nurse Practitioners;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.06#B(4)">(4)</span> RNs and LPNs;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.06#B(5)">(5)</span> Chiropractors;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.06#B(6)">(6)</span> Dentists;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.06#B(7)">(7)</span> Dietitian-Nutritionists;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.06#B(8)">(8)</span> Occupational therapists;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.06#B(9)">(9)</span> Social workers;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.06#B(10)">(10)</span> Speech-language pathologists; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.06#B(11)">(11)</span> CNAs, HHAs, CNA-CMTs, and HHA-CMTs.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.69.06#C">C.</span> A provider rendering services pursuant to this chapter shall meet all applicable licensure and certification requirements of the jurisdiction in which the provider is providing services.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.69.06#D">D.</span> A provider rendering services to REM participants, pursuant to this chapter, may not have current sanctions or current disciplinary actions imposed by:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.06#D(1)">(1)</span> The jurisdictional licensing or certification authority;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.06#D(2)">(2)</span> The Medicare Program;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.06#D(3)">(3)</span> The Program; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.06#D(4)">(4)</span> Other federally funded healthcare programs.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.09.69.07" data-order="|10|09|69|.07|" data-ref-path="10|09|69|.07" class="h__section">.07 Conditions for Participation — General Requirements.</h2>
                <p>A provider rendering services pursuant to this chapter shall:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.69.07#A">A.</span> Meet the applicable conditions for participation set forth in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.36" title="Chapter 36 General Medical Assistance Provider Participation Criteria">COMAR 10.09.36</a>;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.69.07#B">B.</span> Meet the provider qualification requirements specified in <a class="internal-link " href="/us/md/exec/comar/10.09.69.06" title=".06 Requirements for Provider Qualification.">Regulation .06 of this chapter</a> for its provider type;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.69.07#C">C.</span> Meet the specific conditions for provider participation set forth in this chapter;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.69.07#D">D.</span> Provide services in accordance with the applicable requirements of this chapter and all other relevant State and local laws and regulations;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.69.07#E">E.</span> Verify the qualifications of all subcontracted or employed professionals and individuals engaged by the provider agency to render services covered under this chapter and provide a copy of their current licensure and credentials on request to the Department;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.69.07#F">F.</span> Provide services to REM program participants in a manner consistent with the REM participant’s plan of care; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.69.07#G">G.</span> When the Department determines it is necessary, participate in the interdisciplinary team meetings for the purpose of:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.07#G(1)">(1)</span> Developing and implementing a participant's treatment plan or plan of care with the Department; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.07#G(2)">(2)</span> Accessing a specific service.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.09.69.08" data-order="|10|09|69|.08|" data-ref-path="10|09|69|.08" class="h__section">.08 Specific Conditions for Provider Participation.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.69.08#A">A.</span> Case Management Providers. To participate in the Program, a case management provider shall meet the conditions set forth in Regulations .06 and .07 of this chapter.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.69.08#B">B.</span> Chiropractic Service Providers. To participate in the Program, the chiropractic service provider shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.08#B(1)">(1)</span> Meet the:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.69.08#B(1)(a)">(a)</span> Conditions set forth in <a class="internal-link " href="/us/md/exec/comar/10.09.69.07" title=".07 Conditions for Participation — General Requirements.">Regulation .07 of this chapter</a>; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.69.08#B(1)(b)">(b)</span> Requirements for chiropractic providers specified in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.43.04" title="Chapter 04 Licensure by Credentials for Chiropractors">COMAR 10.43.04</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.08#B(2)">(2)</span> Develop a goal-directed treatment plan that is based on an evaluation conducted during the initial assessment, which requires:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.69.08#B(2)(a)">(a)</span> A review or evaluation of the treatment plan 30 days after the initial assessment; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.69.08#B(2)(b)">(b)</span> A review and update of the treatment plan every 90 days; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.08#B(3)">(3)</span> Render services in accordance with orders written by a physician, physician assistant, or nurse practitioner.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.69.08#C">C.</span> Dental Service Providers. To participate in the Program, the dental service provider shall meet the:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.08#C(1)">(1)</span> Conditions set forth in <a class="internal-link " href="/us/md/exec/comar/10.09.69.07" title=".07 Conditions for Participation — General Requirements.">Regulation .07 of this chapter</a>; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.08#C(2)">(2)</span> Requirements for dental providers specified in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.05" title="Chapter 05 Dental Services">COMAR 10.09.05</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.69.08#D">D.</span> Nutritional Supplement Providers. To participate as a provider of nutritional supplements, a provider shall meet the:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.08#D(1)">(1)</span> Conditions of participation as set forth in <a class="internal-link " href="/us/md/exec/comar/10.09.69.07" title=".07 Conditions for Participation — General Requirements.">Regulation .07 of this chapter</a>; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.08#D(2)">(2)</span> Criteria of the conditions for participation for pharmacy providers set forth in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.03" title="Chapter 03 Pharmacy Services">COMAR 10.09.03</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.69.08#E">E.</span> Shift Private Duty Nursing/CNA/CNA-CMT/HHA/HHA-CMT Providers. To participate as a provider agency for shift private duty nursing, CNA, CNA-CMT, HHA, or HHA-CMT services, a provider shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.08#E(1)">(1)</span> Meet the conditions set forth in <a class="internal-link " href="/us/md/exec/comar/10.09.69.07" title=".07 Conditions for Participation — General Requirements.">Regulation .07 of this chapter</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.08#E(2)">(2)</span> Meet all requirements of conditions for participation set forth in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.53.03" title=".03 Conditions for Participation.">COMAR 10.09.53.03</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.08#E(3)">(3)</span> Participate in interdisciplinary team meetings, when requested by the Department or its designee;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.08#E(4)">(4)</span> Develop a goal-directed written nursing care plan that is based on an evaluation conducted during the initial assessment, which requires:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.69.08#E(4)(a)">(a)</span> A review or evaluation of the nursing care plan 30 days after the initial assessment; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.69.08#E(4)(b)">(b)</span> A review and update of the nursing care plan every 90 days;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.08#E(5)">(5)</span> Ensure timesheets are signed by the individual rendering services;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.08#E(6)">(6)</span> Ensure a nurse's, CNA’s, CNA-CMT’s, HHA’s, or HHA-CMT’s shift to be not more than a total of 60 hours per week or 16 consecutive hours and that the individual is off 8 or more hours before starting another shift unless otherwise authorized by the Department;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.08#E(7)">(7)</span> Obtain the participant's signature or the signature of the participant's witness on the provider's official forms to verify receipt of service; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.08#E(8)">(8)</span> Be licensed as a:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.69.08#E(8)(a)">(a)</span> Residential service agency in accordance with <a class="internal-link no-wrap" href="/us/md/exec/comar/10.07.05" title="Chapter 05 Residential Service Agencies">COMAR 10.07.05</a>; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.69.08#E(8)(b)">(b)</span> Home health agency in accordance with <a class="internal-link no-wrap" href="/us/md/exec/comar/10.07.10" title="Chapter 10 Home Health Agencies">COMAR 10.07.10</a> which meets the conditions of participation specified by the Medicare program in 42 CFR §484.36.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.69.08#F">F.</span> Occupational Therapy Providers. To participate in the Program as a provider of occupational therapy services, a provider shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.08#F(1)">(1)</span> Meet the conditions set forth in <a class="internal-link " href="/us/md/exec/comar/10.09.69.07" title=".07 Conditions for Participation — General Requirements.">Regulation .07 of this chapter</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.08#F(2)">(2)</span> Be a self-employed occupational therapist licensed according to <a class="internal-link no-wrap" href="/us/md/exec/comar/10.46.01" title="Chapter 01 General Regulations">COMAR 10.46.01</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.08#F(3)">(3)</span> Be an agency or clinic which employs occupational therapists or be a Program provider of home health services under <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.04" title="Chapter 04 Home Health Services">COMAR 10.09.04</a>; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.08#F(4)">(4)</span> Develop a goal-directed written treatment plan that is based on an evaluation conducted during the initial assessment which requires:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.69.08#F(4)(a)">(a)</span> A review or evaluation of the treatment plan 30 days after the initial assessment; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.69.08#F(4)(b)">(b)</span> A review and update of the treatment plan every 90 days.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.69.08#G">G.</span> Speech-Language Pathology Providers. To participate in the Program, a speech-language pathology provider shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.08#G(1)">(1)</span> Meet the conditions set forth in <a class="internal-link " href="/us/md/exec/comar/10.09.69.07" title=".07 Conditions for Participation — General Requirements.">Regulation .07 of this chapter</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.08#G(2)">(2)</span> Be a self-employed speech-language pathologist according to <a class="internal-link no-wrap" href="/us/md/exec/comar/10.41.03" title="Chapter 03 Licensure and Continuing Education">COMAR 10.41.03</a> or be a Program provider of home health services under <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.04" title="Chapter 04 Home Health Services">COMAR 10.09.04</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.08#G(3)">(3)</span> Be an agency or clinic that employs speech-language pathologists; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.08#G(4)">(4)</span> Develop a goal-directed written treatment plan that is based on an initial assessment, which requires:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.69.08#G(4)(a)">(a)</span> A review or evaluation of the treatment plan 30 days after the initial assessment; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.69.08#G(4)(b)">(b)</span> A review and update of the treatment plan every 90 days.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.09.69.09" data-order="|10|09|69|.09|" data-ref-path="10|09|69|.09" class="h__section">.09 Covered Services — General Requirements.</h2>
                <p>For participants in the REM program, the Program covers and shall reimburse for services specified in Regulations .10 and .11 of this chapter when these services are:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.69.09#A">A.</span> Medically necessary;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.69.09#B">B.</span> Prescribed by a:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.09#B(1)">(1)</span> Physician;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.09#B(2)">(2)</span> Physician assistant; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.09#B(3)">(3)</span> Nurse practitioner;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.69.09#C">C.</span> Preauthorized, when required, by the Department;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.69.09#D">D.</span> Rendered in accordance with accepted health professional standards;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.69.09#E">E.</span> Rendered in accordance with the treatment plan or physician's, physician assistant’s, or nurse practitioner’s order, or both; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.69.09#F">F.</span> Delivered by an enrolled Medical Assistance provider.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.09.69.10" data-order="|10|09|69|.10|" data-ref-path="10|09|69|.10" class="h__section">.10 Covered Services.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.69.10#A">A.</span> Chiropractic services are covered for REM participants when:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.10#A(1)">(1)</span> Services are provided to a REM participant who is 21 years old or older;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.10#A(2)">(2)</span> Services are provided by a physician or chiropractor;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.10#A(3)">(3)</span> The qualifying REM diagnosis or related illness shows deterioration or worsening symptoms and other traditional treatments have been ineffective;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.10#A(4)">(4)</span> The treatment enhances or restores the participant's level of functioning; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.10#A(5)">(5)</span> Symptoms resulting from the REM diagnosis or related illness impairs a participant's activities of daily living.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.69.10#B">B.</span> Dental services are covered when services are:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.10#B(1)">(1)</span> Provided to a REM participant who is 21 years old or older; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.10#B(2)">(2)</span> Rendered as specified in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.05" title="Chapter 05 Dental Services">COMAR 10.09.05</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.69.10#C">C.</span> Nutritional counseling services are covered when services are provided:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.10#C(1)">(1)</span> To a REM participant who is 21 years old or older; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.10#C(2)">(2)</span> By a dietitian-nutritionist.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.69.10#D">D.</span> Nutritional supplements are covered when the services:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.10#D(1)">(1)</span> Include nutritional supplements or enteral feeding when medically necessary other than those administered by tube; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.10#D(2)">(2)</span> Are as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.03" title="Chapter 03 Pharmacy Services">COMAR 10.09.03</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.69.10#E">E.</span> The Department shall cover a physician's, physician assistant’s, or nurse practitioner’s participation at interdisciplinary team meetings when the case manager, in conjunction with the team or specific team members, convenes the team meeting for the purpose of developing or reviewing the REM participant's plan of care to ensure continuity of care or access to a specific service.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.69.10#F">F.</span> Occupational therapy services are covered when services are provided:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.10#F(1)">(1)</span> To a REM participant who is 21 years old or older;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.10#F(2)">(2)</span> By an occupational therapist; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.10#F(3)">(3)</span> In accordance with <a class="internal-link no-wrap" href="/us/md/exec/comar/10.46.01" title="Chapter 01 General Regulations">COMAR 10.46.01</a> and <a class="internal-link no-wrap" href="/us/md/exec/comar/10.46.02" title="Chapter 02 Code of Ethics">10.46.02</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.69.10#G">G.</span> Speech-language pathology services include only those services that are provided:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.10#G(1)">(1)</span> To a REM participant who is 21 years old or older;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.10#G(2)">(2)</span> By a speech-language pathologist; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.10#G(3)">(3)</span> In accordance with <a class="internal-link no-wrap" href="/us/md/exec/comar/10.41.02" title="Chapter 02 Code of Ethics">COMAR 10.41.02</a> and <a class="internal-link no-wrap" href="/us/md/exec/comar/10.41.03" title="Chapter 03 Licensure and Continuing Education">10.41.03</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.09.69.11" data-order="|10|09|69|.11|" data-ref-path="10|09|69|.11" class="h__section">.11 Covered Optional Services — Private Duty Nursing, Certified Nursing Assistant, Certified Nursing Assistant Certified as a Certified Medication Technician, Home Health Aide and Home Health Aide Certified as a Certified Medication Technician.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.69.11#A">A.</span> The Program shall cover shift nursing services provided by an RN or LPN when:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.11#A(1)">(1)</span> The services are more individualized and continuous than what is available under the home health program;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.11#A(2)">(2)</span> The services are delivered to the participant in the participant's home, in school, or in other normal life activity setting or settings which occur outside the participant's home;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.11#A(3)">(3)</span> Services are provided to a REM participant who is 21 years old or older;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.11#A(4)">(4)</span> Services are determined medically necessary for a participant after the provider has completed an initial nursing assessment that reflects the participant’s need for an awake and alert caregiver;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.11#A(5)">(5)</span> The participant has at least one caregiver willing and able to accept responsibility for the participant’s care when the nurse, CNA, or HHA is not available;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.11#A(6)">(6)</span> The caregiver provides documentation of each of the following when applicable:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.69.11#A(6)(a)">(a)</span> The caregiver’s work schedule along with commuting times;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.69.11#A(6)(b)">(b)</span> The caregiver’s school attendance as defined in <a class="internal-link " href="/us/md/exec/comar/10.09.69.02" title=".02 Definitions.">Regulation .02 of this chapter</a> along with commuting times; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.69.11#A(6)(c)">(c)</span> Emergency circumstances, as determined by the Department, including but not limited to the inability of the primary caregiver to provide care due to hospitalization or an acute debilitating illness for up to a 60-day period;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.11#A(7)">(7)</span> Services are provided only in the absence of the willing and able caregiver during the sleeping hours and during the times documented in <a class="internal-link " href="/us/md/exec/comar/10.09.69.11#A(6)" title="">§A(6) of this regulation</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.11#A(8)">(8)</span> Services are rendered in accordance with <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gho/gho.pdf" title="">Health Occupations Article, Title 8, Annotated Code of Maryland</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.11#A(9)">(9)</span> Sufficient documentation concerning the services provided is maintained by the RN or LPN including:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.69.11#A(9)(a)">(a)</span> Verification of the participant's receipt of services as documented by the participant's signature or the signature of the participant's witness on the provider's official forms; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.69.11#A(9)(b)">(b)</span> Signed and dated progress notes which are reviewed monthly by the RN supervisor;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.11#A(10)">(10)</span> The nurse's shift is limited to not more than a total of 60 hours per week or 16 consecutive hours and the nurse is off 8 or more hours before starting another shift unless otherwise authorized by the Department;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.11#A(11)">(11)</span> Services are rendered by an RN or an LPN who is certified in cardiopulmonary resuscitation and the certification is renewed every 2 years; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.11#A(12)">(12)</span> Monthly supervisory visits of an RN or an LPN are:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.69.11#A(12)(a)">(a)</span> Conducted and documented by an RN supervisor; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.69.11#A(12)(b)">(b)</span> Based on acceptable standards of practice.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.69.11#B">B.</span> The Program shall cover service`s provided by a CNA or CNA-CMT when:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.11#B(1)">(1)</span> The CNA or CNA-CMT is certified by the Maryland Board of Nursing and meets all the requirements to render services pursuant to <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gho/gho.pdf" title="">Health Occupations Article, Title 8, Annotated Code of Maryland</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.11#B(2)">(2)</span> The CNA-CMT has completed the training and has been certified by the Maryland Board of Nursing as a CMT;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.11#B(3)">(3)</span> Services are of a scope that is more individual and continuous than what is available under the home health program;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.11#B(4)">(4)</span> The services provided include but are not limited to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.69.11#B(4)(a)">(a)</span> Assistance with activities of daily living when performed in conjunction with other delegated nursing services; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.69.11#B(4)(b)">(b)</span> Other health care services properly delegated by an RN or an LPN pursuant to <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gho/gho.pdf" title="">Health Occupations Article, Title 8, Annotated Code of Maryland</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.11#B(5)">(5)</span> Services are rendered by a CNA or CNA-CMT who is certified in cardiopulmonary resuscitation and the certification is renewed every 2 years;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.11#B(6)">(6)</span> The CNAs or CNA-CMTs shift is limited to not more than a total of 60 hours per week or 16 consecutive hours and the CNA or CNA-CMT has 8 hours or more off before starting another shift unless otherwise authorized by the Department;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.11#B(7)">(7)</span> Sufficient documentation concerning the services provided is maintained by the CNA or CNA-CMT including:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.69.11#B(7)(a)">(a)</span> Verification of the participant's receipt of services as documented by the participant's signature or the signature of the participant's witness on the provider's official forms; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.69.11#B(7)(b)">(b)</span> Signed and dated progress notes which are reviewed every 2 weeks by the RN supervisor;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.11#B(8)">(8)</span> Supervisory visits are conducted and documented every 2 weeks by an RN;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.11#B(9)">(9)</span> The services are included in the REM participant's plan of care developed by the case manager; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.11#B(10)">(10)</span> Services are preauthorized by the Department.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.69.11#C">C.</span> The Program shall cover services provided by a HHA or HHA-CMT when:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.11#C(1)">(1)</span> Services are provided by an unlicensed individual who meets all the conditions of participation specified by the Medicare program in 42 CFR §484.36 and <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gho/gho.pdf" title="">Health Occupations Article, Title 8, Annotated Code of Maryland</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.11#C(2)">(2)</span> The HHA-CMT has completed the training and has been certified by the Maryland Board of Nursing as a CMT;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.11#C(3)">(3)</span> Services are more individualized and continuous than what is available under the home health program;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.11#C(4)">(4)</span> The services provided include but are not limited to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.69.11#C(4)(a)">(a)</span> Assistance with activities of daily living when performed in conjunction with other delegated nursing services; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.69.11#C(4)(b)">(b)</span> Other health care services properly delegated by an RN or LPN pursuant to <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gho/gho.pdf" title="">Health Occupations Article, Title 8, Annotated Code of Maryland</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.11#C(5)">(5)</span> Services are rendered by a HHA or HHA-CMT who is certified in cardiopulmonary resuscitation and the certification is renewed every 2 years;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.11#C(6)">(6)</span> The HHAs or HHA-CMTs shift is limited to not more than a total of 60 hours per week or 16 consecutive hours and the HHA or HHA-CMT has 8 hours or more off before starting another shift unless otherwise authorized by the Department;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.11#C(7)">(7)</span> Sufficient documentation is maintained by the HHA or HHA-CMT including:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.69.11#C(7)(a)">(a)</span> Verification of the participant's receipt of services as documented by the participant's signature or the signature of the participant's witness on the provider's official forms; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.69.11#C(7)(b)">(b)</span> Signed and dated progress notes which are reviewed every 2 weeks by the RN supervisor;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.11#C(8)">(8)</span> Supervisory visits are conducted and documented every 2 weeks by an RN;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.11#C(9)">(9)</span> The services are included in the REM participant's plan of care developed by the case manager; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.11#C(10)">(10)</span> Services are preauthorized by the Department.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.09.69.12" data-order="|10|09|69|.12|" data-ref-path="10|09|69|.12" class="h__section">.12 Limitations.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.69.12#A">A.</span> The Department shall pay for services specified in this chapter delivered to a REM participant only if the services have been ordered by the participant's physician or nurse practitioner, and preauthorized, when necessary, by the Department or its designee.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.69.12#B">B.</span> For REM participants, the Department may not pay for the following comparable case management services:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.12#B(1)">(1)</span> HIV targeted case management as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.32" title="Chapter 32 Targeted Case Management for HIV-Infected Individuals">COMAR 10.09.32</a>, except for HIV Diagnostic Evaluation Services as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.32.03#C" title="">COMAR 10.09.32.03C</a> and .04A; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.12#B(2)">(2)</span> Model Waiver case management as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.27" title="Chapter 27 Home Care for Disabled Children Under a Model Waiver">COMAR 10.09.27</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.69.12#C">C.</span> The REM program does not cover the following:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.12#C(1)">(1)</span> Shift private duty nursing, CNA or CNA-CMT, or HHA or HHA-CMT services rendered by a nurse, CNA, HHA, CNA-CMT, or HHA-CMT who is a member of the participant's immediate family or who ordinarily resides with the participant;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.12#C(2)">(2)</span> Services which are not medically necessary;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.12#C(3)">(3)</span> Services not supervised by an RN when delivered by the following:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.69.12#C(3)(a)">(a)</span> An RN or an LPN;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.69.12#C(3)(b)">(b)</span> A CNA;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.69.12#C(3)(c)">(c)</span> An HHA;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.69.12#C(3)(d)">(d)</span> A CNA-CMT; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.69.12#C(3)(e)">(e)</span> An HHA-CMT.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.12#C(4)">(4)</span> REM optional services not preauthorized as required by the Department or its designee;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.12#C(5)">(5)</span> REM optional services not prescribed by the participant's physician, physician assistant, or nurse practitioner;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.12#C(6)">(6)</span> Services specified in this chapter which duplicate or supplant services rendered by the participant's family caregivers or primary caregivers as well as other insurance, privilege, entitlement, or Program services that the participant receives or is eligible to receive;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.12#C(7)">(7)</span> Services provided for the convenience or preference of the participant or the primary caregiver rather than required by the participant's medical condition;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.12#C(8)">(8)</span> Speech, language, or occupational therapy services rendered in a classroom setting;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.12#C(9)">(9)</span> Shift private duty nursing, CNA, CNA-CMT, HHA, or HHA-CMT services ordered by a physician assistant;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.12#C(10)">(10)</span> Custodial services;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.12#C(11)">(11)</span> Services provided to a participant in a:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.69.12#C(11)(a)">(a)</span> Hospital;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.69.12#C(11)(b)">(b)</span> Residential treatment center;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.69.12#C(11)(c)">(c)</span> Intermediate care facility for individuals with intellectual disabilities; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.69.12#C(11)(d)">(d)</span> Residence or facility where nursing services are included in the living arrangement by regulation or statute, or otherwise provided for payment;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.12#C(12)">(12)</span> Services not directly related to the participant’s plan of care;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.12#C(13)">(13)</span> Services described in the plan of care whenever a major change occurs in the participant's medical condition or skilled nursing care needs that indicates such services are no longer necessary;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.12#C(14)">(14)</span> Services which are not initially ordered before the start of care and renewed every 60 days by the participant’s primary medical provider;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.12#C(15)">(15)</span> Services provided by a nurse, CNA, or HHA who does not possess a valid, current, and nontemporary nursing license or certifications to provide services in the jurisdiction in which nursing services are rendered;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.12#C(16)">(16)</span> Services provided by a nurse, CNA, or HHA who does not have a current cardiopulmonary resuscitation (CPR) certification for the period during which the services are rendered;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.12#C(17)">(17)</span> Direct payment for supervisory visits that do not meet acceptable standards of practice in accordance with <a class="internal-link no-wrap" href="/us/md/exec/comar/10.27.09" title="Chapter 09 Standards of Practice for Registered Nurses">COMAR 10.27.09</a>, <a class="internal-link no-wrap" href="/us/md/exec/comar/10.27.10" title="Chapter 10 Standards of Practice for Licensed Practical Nurses">10.27.10</a>, and <a class="internal-link no-wrap" href="/us/md/exec/comar/10.27.11" title="Chapter 11 Delegation of Nursing Functions">10.27.11</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.12#C(18)">(18)</span> Services rendered to a participant by a nurse, CNA, or HHA in the assigned staff’s home;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.12#C(19)">(19)</span> Services not documented; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.12#C(20)">(20)</span> Respite services.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.69.12#D">D.</span> The Program shall only cover one-to-one nursing when a participant’s condition requires that level of service and shared services are not an option.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.69.12#E">E.</span> The Program shall only cover nursing services ordered by an individual who is enrolled as a provider in the Program with an active status on the date of service.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.09.69.13" data-order="|10|09|69|.13|" data-ref-path="10|09|69|.13" class="h__section">.13 Preauthorization Requirements.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.69.13#A">A.</span> Except for initial assessments unless otherwise specified, preauthorization by the Department or its designee is required for all services under Regulations .10 and .11 of this chapter.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.69.13#B">B.</span> The Department or its designee shall issue preauthorization when the Department:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.13#B(1)">(1)</span> Determines that services are medically necessary; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.13#B(2)">(2)</span> Authorizes the services before the initiation or continuance of the requested service.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.69.13#C">C.</span> Authorization of services shall be rescinded by the Department or its designee when:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.13#C(1)">(1)</span> The participant is admitted to a hospital, residential treatment center, nursing facility, or ICF/IID;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.13#C(2)">(2)</span> The participant is no longer REM eligible;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.13#C(3)">(3)</span> The Department determines the care is no longer medically necessary; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.13#C(4)">(4)</span> The participant dies.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.09.69.14" data-order="|10|09|69|.14|" data-ref-path="10|09|69|.14" class="h__section">.14 Payment Procedures — Request for Payment.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.69.14#A">A.</span> A provider shall submit a request for payment for the services covered under this chapter according to the procedures set forth in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.36" title="Chapter 36 General Medical Assistance Provider Participation Criteria">COMAR 10.09.36</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.69.14#B">B.</span> Billing time limitations for the services covered under this chapter are the same as those set forth in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.36" title="Chapter 36 General Medical Assistance Provider Participation Criteria">COMAR 10.09.36</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.69.14#C">C.</span> The Department shall pay for covered services at the lower of:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.14#C(1)">(1)</span> The lowest price, including negotiated contract prices, that is offered to any other purchaser for the same or similar service during the same time period, after extending to the Program all rebates, coupons, and negotiated discounts;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.14#C(2)">(2)</span> The actual charge billed by the provider; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.14#C(3)">(3)</span> Any fee schedule developed for reimbursement of the same service provided under Medical Assistance.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.69.14#D">D.</span> For dates of service from January 1, 2021, through June 30, 2022, the Department shall pay $445.86 for a case management assessment, as described in <a class="internal-link " href="/us/md/exec/comar/10.09.69.05#C" title="">Regulation .05C of this chapter</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.69.14#E">E.</span> For dates of service from January 1, 2021, through June 30, 2022, the Department shall make payments monthly for case management services at one of the rates specified below:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.14#E(1)">(1)</span> Level of Care 1: $329.22;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.14#E(2)">(2)</span> Level of Care 2: $196.22; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.14#E(3)">(3)</span> Level of Care 3: $103.56.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.69.14#F">F.</span> Effective July 1, 2022, the Department shall pay $463.69 for a case management assessment, as described in <a class="internal-link " href="/us/md/exec/comar/10.09.69.05#C" title="">Regulation .05C of this chapter</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.69.14#G">G.</span> Effective July 1, 2022, the Department shall make payments monthly for case management services at one of the rates specified below:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.14#G(1)">(1)</span> Level of Care 1: $342.39;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.14#G(2)">(2)</span> Level of Care 2: $204.07; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.14#G(3)">(3)</span> Level of Care 3: $107.70.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.69.14#H">H.</span> The rates found in §§E and G of this regulation are the monthly rates paid by the Department for a participant receiving case management as follows:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.14#H(1)">(1)</span> Level of Care 1 is intensive level of case management, assessment, and coordination of services for a participant who:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.69.14#H(1)(a)">(a)</span> Is acutely ill;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.69.14#H(1)(b)">(b)</span> Has an unstable clinical condition;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.69.14#H(1)(c)">(c)</span> Has an exacerbated chronic illness; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.69.14#H(1)(d)">(d)</span> Has a newly diagnosed condition;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.14#H(2)">(2)</span> Level of Care 2 is case management to a participant who has a history of exacerbations of medical issues requiring services on an ongoing basis to attain stable service or treatment plans; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.69.14#H(3)">(3)</span> Level of Care 3 is case management that is required on an ongoing basis to monitor a participant’s stability and treatment plans.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.09.69.15" data-order="|10|09|69|.15|" data-ref-path="10|09|69|.15" class="h__section">.15 Recovery and Reimbursement.</h2>
                <p>Recovery and reimbursement under this chapter are set forth in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.36" title="Chapter 36 General Medical Assistance Provider Participation Criteria">COMAR 10.09.36</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.09.69.16" data-order="|10|09|69|.16|" data-ref-path="10|09|69|.16" class="h__section">.16 Cause for Suspension or Removal and Imposition of Sanctions.</h2>
                <p>Cause for suspension or removal and imposition of sanctions is set forth in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.36" title="Chapter 36 General Medical Assistance Provider Participation Criteria">COMAR 10.09.36</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.09.69.17" data-order="|10|09|69|.17|" data-ref-path="10|09|69|.17" class="h__section">.17 Table of Rare and Expensive Disease Diagnosis.</h2>
                <div class="table_wrap">
                  <table>
                    <thead>
                      <tr>
                        <th data-width="166666">ICD10</th>
                        <th data-width="666666">ICD 10 Description</th>
                        <th data-width="166666">Age Limit</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">B20</td>
                        <td data-vertical-align="middle" data-width="666666">Human immunodeficiency virus (HIV) disease</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">C96.0</td>
                        <td data-vertical-align="middle" data-width="666666">Multifocal and multisystemic Langerhans-cell histiocytosis</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">C96.5</td>
                        <td data-vertical-align="middle" data-width="666666">Multifocal and unisystemic Langerhans-cell histiocytosis</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">C96.6</td>
                        <td data-vertical-align="middle" data-width="666666">Unifocal Langerhans-cell histiocytosis</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">D61.01</td>
                        <td data-vertical-align="middle" data-width="666666">Constitutional (pure) red blood cell aplasia</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">D61.09</td>
                        <td data-vertical-align="middle" data-width="666666">Other constitutional aplastic anemia</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">D66</td>
                        <td data-vertical-align="middle" data-width="666666">Hereditary factor VIII deficiency</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">D67</td>
                        <td data-vertical-align="middle" data-width="666666">Hereditary factor IX deficiency</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">D68.00</td>
                        <td data-vertical-align="middle" data-width="666666">Von Willebrand disease, unspecified</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">D68.01</td>
                        <td data-vertical-align="middle" data-width="666666">Von Willebrand disease, type 1</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">D68.020</td>
                        <td data-vertical-align="middle" data-width="666666">Von Willebrand disease, type 2A</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">D68.021</td>
                        <td data-vertical-align="middle" data-width="666666">Von Willebrand disease, type 2B</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">D68.022</td>
                        <td data-vertical-align="middle" data-width="666666">Von Willebrand disease, type 2M</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">D68.023</td>
                        <td data-vertical-align="middle" data-width="666666">Von Willebrand disease, type 2N</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">D68.029</td>
                        <td data-vertical-align="middle" data-width="666666">Von Willebrand disease, type 2, unspecified</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">D68.03</td>
                        <td data-vertical-align="middle" data-width="666666">Von Willebrand disease, type 3</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">D68.04</td>
                        <td data-vertical-align="middle" data-width="666666">Acquired von Willebrand disease</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">D68.09</td>
                        <td data-vertical-align="middle" data-width="666666">Other von Willebrand disease</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">D68.1</td>
                        <td data-vertical-align="middle" data-width="666666">Hereditary factor XI deficiency</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">D68.2</td>
                        <td data-vertical-align="middle" data-width="666666">Hereditary deficiency of other clotting factors</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E70.0</td>
                        <td data-vertical-align="middle" data-width="666666">Classical phenylketonuria</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E70.1</td>
                        <td data-vertical-align="middle" data-width="666666">Other hyperphenylalaninemias</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E70.20</td>
                        <td data-vertical-align="middle" data-width="666666">Disorder of tyrosine metabolism, unspecified</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E70.21</td>
                        <td data-vertical-align="middle" data-width="666666">Tyrosinemia</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E70.29</td>
                        <td data-vertical-align="middle" data-width="666666">Other disorders of tyrosine metabolism</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E70.30</td>
                        <td data-vertical-align="middle" data-width="666666">Albinism, unspecified</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E70.40</td>
                        <td data-vertical-align="middle" data-width="666666">Disorders of histidine metabolism, unspecified</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E70.41</td>
                        <td data-vertical-align="middle" data-width="666666">Histidinemia</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E70.49</td>
                        <td data-vertical-align="middle" data-width="666666">Other disorders of histidine metabolism</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E70.5</td>
                        <td data-vertical-align="middle" data-width="666666">Disorders of tryptophan metabolism</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E70.81</td>
                        <td data-vertical-align="middle" data-width="666666">Aromatic L-amino acid decarboxylase deficiency</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E70.89</td>
                        <td data-vertical-align="middle" data-width="666666">Other disorders of amino-acid metabolism</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E71.110</td>
                        <td data-vertical-align="middle" data-width="666666">Isovaleric acidemia</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E71.111</td>
                        <td data-vertical-align="middle" data-width="666666">3-methylglutaconic aciduria</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E71.118</td>
                        <td data-vertical-align="middle" data-width="666666">Other branched-chain organic acidurias</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E71.120</td>
                        <td data-vertical-align="middle" data-width="666666">Methylmalonic acidemia</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E71.121</td>
                        <td data-vertical-align="middle" data-width="666666">Propionic acidemia</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E71.128</td>
                        <td data-vertical-align="middle" data-width="666666">Other disorders of propionate metabolism</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E71.19</td>
                        <td data-vertical-align="middle" data-width="666666">Other disorders of branched-chain amino-acid metabolism</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E71.2</td>
                        <td data-vertical-align="middle" data-width="666666">Disorder of branched-chain amino-acid metabolism, unspecified</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E71.310</td>
                        <td data-vertical-align="middle" data-width="666666">Long chain/very long chain acyl CoA dehydrogenase deficiency</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E71.311</td>
                        <td data-vertical-align="middle" data-width="666666">Medium chain acyl CoA dehydrogenase deficiency</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E71.312</td>
                        <td data-vertical-align="middle" data-width="666666">Short chain acyl CoA dehydrogenase deficiency</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E71.313</td>
                        <td data-vertical-align="middle" data-width="666666">Glutaric aciduria type II</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E71.314</td>
                        <td data-vertical-align="middle" data-width="666666">Muscle carnitine palmitoyltransferase deficiency</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E71.318</td>
                        <td data-vertical-align="middle" data-width="666666">Other disorders of fatty-acid oxidation</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E71.32</td>
                        <td data-vertical-align="middle" data-width="666666">Disorders of ketone metabolism</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E71.39</td>
                        <td data-vertical-align="middle" data-width="666666">Other disorders of fatty-acid metabolism</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E71.41</td>
                        <td data-vertical-align="middle" data-width="666666">Primary carnitine deficiency</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E71.42</td>
                        <td data-vertical-align="middle" data-width="666666">Carnitine deficiency due to inborn errors of metabolism</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E71.50</td>
                        <td data-vertical-align="middle" data-width="666666">Peroxisomal disorder, unspecified</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E71.510</td>
                        <td data-vertical-align="middle" data-width="666666">Zellweger syndrome</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E71.511</td>
                        <td data-vertical-align="middle" data-width="666666">Neonatal adrenoleukodystrophy</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E71.518</td>
                        <td data-vertical-align="middle" data-width="666666">Other disorders of peroxisome biogenesis</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E71.520</td>
                        <td data-vertical-align="middle" data-width="666666">Childhood cerebral X-linked adrenoleukodystrophy</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E71.521</td>
                        <td data-vertical-align="middle" data-width="666666">Adolescent X-linked adrenoleukodystrophy</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E71.522</td>
                        <td data-vertical-align="middle" data-width="666666">Adrenomyeloneuropathy</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E71.528</td>
                        <td data-vertical-align="middle" data-width="666666">Other X-linked adrenoleukodystrophy</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E71.529</td>
                        <td data-vertical-align="middle" data-width="666666">X-linked adrenoleukodystrophy, unspecified type</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E71.53</td>
                        <td data-vertical-align="middle" data-width="666666">Other group 2 peroxisomal disorders</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E71.540</td>
                        <td data-vertical-align="middle" data-width="666666">Rhizomelic chondrodysplasia punctata</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E71.541</td>
                        <td data-vertical-align="middle" data-width="666666">Zellweger-like syndrome</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E71.542</td>
                        <td data-vertical-align="middle" data-width="666666">Other group 3 peroxisomal disorders</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E71.548</td>
                        <td data-vertical-align="middle" data-width="666666">Other peroxisomal disorders</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E72.01</td>
                        <td data-vertical-align="middle" data-width="666666">Cystinuria</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E72.02</td>
                        <td data-vertical-align="middle" data-width="666666">Hartnup’s disease</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E72.03</td>
                        <td data-vertical-align="middle" data-width="666666">Lowe’s syndrome</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E72.04</td>
                        <td data-vertical-align="middle" data-width="666666">Cystinosis</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E72.09</td>
                        <td data-vertical-align="middle" data-width="666666">Other disorders of amino-acid transport</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E72.11</td>
                        <td data-vertical-align="middle" data-width="666666">Homocystinuria</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E72.12</td>
                        <td data-vertical-align="middle" data-width="666666">Methylenetetrahydrofolate reductase deficiency</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E72.19</td>
                        <td data-vertical-align="middle" data-width="666666">Other disorders of sulfur-bearing amino-acid metabolism</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E72.20</td>
                        <td data-vertical-align="middle" data-width="666666">Disorder of urea cycle metabolism, unspecified</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E72.21</td>
                        <td data-vertical-align="middle" data-width="666666">Argininemia</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E72.22</td>
                        <td data-vertical-align="middle" data-width="666666">Arginosuccinic aciduria</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E72.23</td>
                        <td data-vertical-align="middle" data-width="666666">Citrullinemia</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E72.29</td>
                        <td data-vertical-align="middle" data-width="666666">Other disorders of urea cycle metabolism</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E72.3</td>
                        <td data-vertical-align="middle" data-width="666666">Disorders of lysine and hydroxylysine metabolism</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E72.4</td>
                        <td data-vertical-align="middle" data-width="666666">Disorders of ornithine metabolism</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E72.51</td>
                        <td data-vertical-align="middle" data-width="666666">Non-ketotic hyperglycinemia</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E72.52</td>
                        <td data-vertical-align="middle" data-width="666666">Trimethylaminuria</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E72.53</td>
                        <td data-vertical-align="middle" data-width="666666">Primary hyperoxaluria</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E72.59</td>
                        <td data-vertical-align="middle" data-width="666666">Other disorders of glycine metabolism</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E72.81</td>
                        <td data-vertical-align="middle" data-width="666666">Disorders of gamma aminobutyric acid metabolism</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E72.89</td>
                        <td data-vertical-align="middle" data-width="666666">Other specified disorders of amino-acid metabolism</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E74.00</td>
                        <td data-vertical-align="middle" data-width="666666">Glycogen storage disease, unspecified</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E74.01</td>
                        <td data-vertical-align="middle" data-width="666666">von Gierke disease</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E74.02</td>
                        <td data-vertical-align="middle" data-width="666666">Pompe disease</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E74.03</td>
                        <td data-vertical-align="middle" data-width="666666">Cori disease</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E74.04</td>
                        <td data-vertical-align="middle" data-width="666666">McArdle disease</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E74.09</td>
                        <td data-vertical-align="middle" data-width="666666">Other glycogen storage disease</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E74.12</td>
                        <td data-vertical-align="middle" data-width="666666">Hereditary fructose intolerance</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E74.19</td>
                        <td data-vertical-align="middle" data-width="666666">Other disorders of fructose metabolism</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E74.21</td>
                        <td data-vertical-align="middle" data-width="666666">Galactosemia</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E74.29</td>
                        <td data-vertical-align="middle" data-width="666666">Other disorders of galactose metabolism</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E74.4</td>
                        <td data-vertical-align="middle" data-width="666666">Disorders of pyruvate metabolism and gluconeogenesis</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E75.00</td>
                        <td data-vertical-align="middle" data-width="666666">GM2 gangliosidosis, unspecified</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E75.01</td>
                        <td data-vertical-align="middle" data-width="666666">Sandhoff disease</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E75.02</td>
                        <td data-vertical-align="middle" data-width="666666">Tay-Sachs disease</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E75.09</td>
                        <td data-vertical-align="middle" data-width="666666">Other GM2 gangliosidosis</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E75.10</td>
                        <td data-vertical-align="middle" data-width="666666">Unspecified gangliosidosis</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E75.11</td>
                        <td data-vertical-align="middle" data-width="666666">Mucolipidosis IV</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E75.19</td>
                        <td data-vertical-align="middle" data-width="666666">Other gangliosidosis</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E75.21</td>
                        <td data-vertical-align="middle" data-width="666666">Fabry (-Anderson) disease</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E75.22</td>
                        <td data-vertical-align="middle" data-width="666666">Gaucher disease</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E75.23</td>
                        <td data-vertical-align="middle" data-width="666666">Krabbe disease</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E75.242</td>
                        <td data-vertical-align="middle" data-width="666666">Niemann-Pick disease type C</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E75.243</td>
                        <td data-vertical-align="middle" data-width="666666">Niemann-Pick disease type D</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E75.244</td>
                        <td data-vertical-align="middle" data-width="666666">Niemann-Pick disease type A/B</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E75.25</td>
                        <td data-vertical-align="middle" data-width="666666">Metachromatic leukodystrophy</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E75.26</td>
                        <td data-vertical-align="middle" data-width="666666">Sulfatase deficiency</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E75.29</td>
                        <td data-vertical-align="middle" data-width="666666">Other sphingolipidosis</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E75.3</td>
                        <td data-vertical-align="middle" data-width="666666">Sphingolipidosis, unspecified</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E75.4</td>
                        <td data-vertical-align="middle" data-width="666666">Neuronal ceroid lipofuscinosis</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E75.5</td>
                        <td data-vertical-align="middle" data-width="666666">Other lipid storage disorders</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E76.01</td>
                        <td data-vertical-align="middle" data-width="666666">Hurler’s syndrome</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E76.02</td>
                        <td data-vertical-align="middle" data-width="666666">Hurler-Scheie syndrome</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E76.03</td>
                        <td data-vertical-align="middle" data-width="666666">Scheie’s syndrome</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E76.1</td>
                        <td data-vertical-align="middle" data-width="666666">Mucopolysaccharidosis, type II</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E76.210</td>
                        <td data-vertical-align="middle" data-width="666666">Morquio A mucopolysaccharidoses</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E76.211</td>
                        <td data-vertical-align="middle" data-width="666666">Morquio B mucopolysaccharidoses</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E76.219</td>
                        <td data-vertical-align="middle" data-width="666666">Morquio mucopolysaccharidoses, unspecified</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E76.22</td>
                        <td data-vertical-align="middle" data-width="666666">Sanfilippo mucopolysaccharidoses</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E76.29</td>
                        <td data-vertical-align="middle" data-width="666666">Other mucopolysaccharidoses</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E76.3</td>
                        <td data-vertical-align="middle" data-width="666666">Mucopolysaccharidosis, unspecified</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E76.8</td>
                        <td data-vertical-align="middle" data-width="666666">Other disorders of glucosaminoglycan metabolism</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E77.0</td>
                        <td data-vertical-align="middle" data-width="666666">Defects in post-translational mod of lysosomal enzymes</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E77.1</td>
                        <td data-vertical-align="middle" data-width="666666">Defects in glycoprotein degradation</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E77.8</td>
                        <td data-vertical-align="middle" data-width="666666">Other disorders of glycoprotein metabolism</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E79.1</td>
                        <td data-vertical-align="middle" data-width="666666">Lesch-Nyhan syndrome</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E79.2</td>
                        <td data-vertical-align="middle" data-width="666666">Myoadenylate deaminase deficiency</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E79.8</td>
                        <td data-vertical-align="middle" data-width="666666">Other disorders of purine and pyrimidine metabolism</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E79.9</td>
                        <td data-vertical-align="middle" data-width="666666">Disorder of purine and pyrimidine metabolism, unspecified</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E80.3</td>
                        <td data-vertical-align="middle" data-width="666666">Defects of catalase and peroxidase</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E84.0</td>
                        <td data-vertical-align="middle" data-width="666666">Cystic fibrosis with pulmonary manifestations</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E84.11</td>
                        <td data-vertical-align="middle" data-width="666666">Meconium ileus in cystic fibrosis</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E84.19</td>
                        <td data-vertical-align="middle" data-width="666666">Cystic fibrosis with other intestinal manifestations</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E84.8</td>
                        <td data-vertical-align="middle" data-width="666666">Cystic fibrosis with other manifestations</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E84.9</td>
                        <td data-vertical-align="middle" data-width="666666">Cystic fibrosis, unspecified</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E88.40</td>
                        <td data-vertical-align="middle" data-width="666666">Mitochondrial metabolism disorder, unspecified</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E88.41</td>
                        <td data-vertical-align="middle" data-width="666666">MELAS syndrome</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E88.42</td>
                        <td data-vertical-align="middle" data-width="666666">MERRF syndrome</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E88.49</td>
                        <td data-vertical-align="middle" data-width="666666">Other mitochondrial metabolism disorders</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">E88.89</td>
                        <td data-vertical-align="middle" data-width="666666">Other specified metabolic disorders</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">F84.2</td>
                        <td data-vertical-align="middle" data-width="666666">Rett’s syndrome</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">G11.0</td>
                        <td data-vertical-align="middle" data-width="666666">Congenital nonprogressive ataxia</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">G11.10</td>
                        <td data-vertical-align="middle" data-width="666666">Early-onset cerebellar ataxia, unspecified</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">G11.11</td>
                        <td data-vertical-align="middle" data-width="666666">Friedreich ataxia</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">G11.19</td>
                        <td data-vertical-align="middle" data-width="666666">Other early-onset cerebellar ataxia</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">G11.2</td>
                        <td data-vertical-align="middle" data-width="666666">Late-onset cerebellar ataxia</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">G11.3</td>
                        <td data-vertical-align="middle" data-width="666666">Cerebellar ataxia with defective DNA repair</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">G11.4</td>
                        <td data-vertical-align="middle" data-width="666666">Hereditary spastic paraplegia</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">G11.8</td>
                        <td data-vertical-align="middle" data-width="666666">Other hereditary ataxias</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">G11.9</td>
                        <td data-vertical-align="middle" data-width="666666">Hereditary ataxia, unspecified</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">G12.0</td>
                        <td data-vertical-align="middle" data-width="666666">Infantile spinal muscular atrophy, type I (Werdnig-Hoffman)</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">G12.1</td>
                        <td data-vertical-align="middle" data-width="666666">Other inherited spinal muscular atrophy</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">G12.21</td>
                        <td data-vertical-align="middle" data-width="666666">Amyotrophic lateral sclerosis</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">G12.22</td>
                        <td data-vertical-align="middle" data-width="666666">Progressive bulbar palsy</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">G12.29</td>
                        <td data-vertical-align="middle" data-width="666666">Other motor neuron disease</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">G12.8</td>
                        <td data-vertical-align="middle" data-width="666666">Other spinal muscular atrophies and related syndromes</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">G12.9</td>
                        <td data-vertical-align="middle" data-width="666666">Spinal muscular atrophy, unspecified</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">G24.1</td>
                        <td data-vertical-align="middle" data-width="666666">Genetic torsion dystonia</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">G24.8</td>
                        <td data-vertical-align="middle" data-width="666666">Other dystonia</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">G25.3</td>
                        <td data-vertical-align="middle" data-width="666666">Myoclonus</td>
                        <td data-text-align="center" data-width="166666">0—5</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">G25.9</td>
                        <td data-vertical-align="middle" data-width="666666">Extrapyramidal and movement disorder, unspecified</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">G31.81</td>
                        <td data-vertical-align="middle" data-width="666666">Alpers disease</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">G31.82</td>
                        <td data-vertical-align="middle" data-width="666666">Leigh’s disease</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">G31.9</td>
                        <td data-vertical-align="middle" data-width="666666">Degenerative disease of nervous system, unspecified</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">G32.81</td>
                        <td data-vertical-align="middle" data-width="666666">Cerebellar ataxia in diseases classified elsewhere</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">G37.0</td>
                        <td data-vertical-align="middle" data-width="666666">Diffuse sclerosis of central nervous system</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">G37.5</td>
                        <td data-vertical-align="middle" data-width="666666">Concentric sclerosis (Balo) of central nervous system</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">G71.00</td>
                        <td data-vertical-align="middle" data-width="666666">Muscular dystrophy, unspecified</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">G71.01</td>
                        <td data-vertical-align="middle" data-width="666666">Duchenne or Becker muscular dystrophy</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">G71.02</td>
                        <td data-vertical-align="middle" data-width="666666">Facioscapulohumeral muscular dystrophy</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">G71.031</td>
                        <td data-vertical-align="middle" data-width="666666">Autosomal dominant limb girdle muscular dystrophy</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">G71.032</td>
                        <td data-vertical-align="middle" data-width="666666">Autosomal recessive limb girdle muscular dystrophy due to calpain-3 dysfunction</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">G71.033</td>
                        <td data-vertical-align="middle" data-width="666666">Limb girdle muscular dystrophy due to dysferlin dysfunction</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">G71.0340</td>
                        <td data-vertical-align="middle" data-width="666666">Limb girdle muscular dystrophy due to sarcoglycan dysfunction, unspecified</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">G71.0341</td>
                        <td data-vertical-align="middle" data-width="666666">Limb girdle muscular dystrophy due to alpha sarcoglycan dysfunction</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">G71.0342</td>
                        <td data-vertical-align="middle" data-width="666666">Limb girdle muscular dystrophy due to beta sarcoglycan dysfunction</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">G71.0349</td>
                        <td data-vertical-align="middle" data-width="666666">Limb girdle muscular dystrophy due to other sarcoglycan dysfunction</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">G71.035</td>
                        <td data-vertical-align="middle" data-width="666666">Limb girdle muscular dystrophy due to anoctamin-5 dysfunction</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">G71.038</td>
                        <td data-vertical-align="middle" data-width="666666">Other limb girdle muscular dystrophy</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">G71.039</td>
                        <td data-vertical-align="middle" data-width="666666">Limb girdle muscular dystrophy, unspecified</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">G71.09</td>
                        <td data-vertical-align="middle" data-width="666666">Other specified muscular dystrophies</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">G71.11</td>
                        <td data-vertical-align="middle" data-width="666666">Myotonic muscular dystrophy</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">G71.20</td>
                        <td data-vertical-align="middle" data-width="666666">Congenital myopathy, unspecified</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">G71.21</td>
                        <td data-vertical-align="middle" data-width="666666">Nemaline myopathy</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">G71.220</td>
                        <td data-vertical-align="middle" data-width="666666">Centronuclear myopathy</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">G71.228</td>
                        <td data-vertical-align="middle" data-width="666666">Other centronuclear myopathy</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">G71.29</td>
                        <td data-vertical-align="middle" data-width="666666">Other congenial myopathy</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">G80.0</td>
                        <td data-vertical-align="middle" data-width="666666">Spastic quadriplegic cerebral palsy</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">G80.1</td>
                        <td data-vertical-align="middle" data-width="666666">Spastic diplegic cerebral palsy</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">G80.3</td>
                        <td data-vertical-align="middle" data-width="666666">Athetoid cerebral palsy</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">G82.50</td>
                        <td data-vertical-align="middle" data-width="666666">Quadriplegia, unspecified</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">G82.51</td>
                        <td data-vertical-align="middle" data-width="666666">Quadriplegia, C1-C4 complete</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">G82.52</td>
                        <td data-vertical-align="middle" data-width="666666">Quadriplegia, C1-C4 incomplete</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">G82.53</td>
                        <td data-vertical-align="middle" data-width="666666">Quadriplegia, C5-C7 complete</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">G82.54</td>
                        <td data-vertical-align="middle" data-width="666666">Quadriplegia, C5-C7 incomplete</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">G91.0</td>
                        <td data-vertical-align="middle" data-width="666666">Communicating hydrocephalus</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">G91.1</td>
                        <td data-vertical-align="middle" data-width="666666">Obstructive hydrocephalus</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">I67.5</td>
                        <td data-vertical-align="middle" data-width="666666">Moyamoya disease</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">K91.2</td>
                        <td data-vertical-align="middle" data-width="666666">Postsurgical malabsorption, not elsewhere classified</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">N03.A</td>
                        <td data-vertical-align="middle" data-width="666666">Chronic nephritic syndrome with C3 glomerulonephritis</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">N03.1</td>
                        <td data-vertical-align="middle" data-width="666666">Chronic nephritic syndrome with focal and segmental glomerular lesions</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">N03.2</td>
                        <td data-vertical-align="middle" data-width="666666">Chronic nephritic syndrome w diffuse membranous glomrlneph</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">N03.3</td>
                        <td data-vertical-align="middle" data-width="666666">Chronic neph syndrome w diffuse mesangial prolif glomrlneph</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">N03.4</td>
                        <td data-vertical-align="middle" data-width="666666">Chronic neph syndrome w diffuse endocaplry prolif glomrlneph</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">N03.5</td>
                        <td data-vertical-align="middle" data-width="666666">Chronic nephritic syndrome w diffuse mesangiocap glomrlneph</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">N03.6</td>
                        <td data-vertical-align="middle" data-width="666666">Chronic nephritic syndrome with dense deposit disease</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">N03.7</td>
                        <td data-vertical-align="middle" data-width="666666">Chronic nephritic syndrome w diffuse crescentic glomrlneph</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">N03.8</td>
                        <td data-vertical-align="middle" data-width="666666">Chronic nephritic syndrome with other morphologic changes</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">N03.9</td>
                        <td data-vertical-align="middle" data-width="666666">Chronic nephritic syndrome with unspecified morphologic changes</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">N08</td>
                        <td data-vertical-align="middle" data-width="666666">Glomerular disorders in diseases classified elsewhere</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">N18.1</td>
                        <td data-vertical-align="middle" data-width="666666">Chronic kidney disease, stage 1</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">N18.2</td>
                        <td data-vertical-align="middle" data-width="666666">Chronic kidney disease, stage 2 (mild)</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">N18.30</td>
                        <td data-vertical-align="middle" data-width="666666">Chronic kidney disease, stage 3, unspecified</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">N18.31</td>
                        <td data-vertical-align="middle" data-width="666666">Chronic kidney disease, stage 3a</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">N18.32</td>
                        <td data-vertical-align="middle" data-width="666666">Chronic kidney disease, stage 3b</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">N18.4</td>
                        <td data-vertical-align="middle" data-width="666666">Chronic kidney disease, stage 4 (severe)</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">N18.5</td>
                        <td data-vertical-align="middle" data-width="666666">Chronic kidney disease, stage 5</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">N18.6</td>
                        <td data-vertical-align="middle" data-width="666666">End stage renal disease</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">N18.9</td>
                        <td data-vertical-align="middle" data-width="666666">Chronic kidney disease, unspecified</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q01.9</td>
                        <td data-vertical-align="middle" data-width="666666">Encephalocele, unspecified</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q02</td>
                        <td data-vertical-align="middle" data-width="666666">Microcephaly</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q03.0</td>
                        <td data-vertical-align="middle" data-width="666666">Malformations of aqueduct of Sylvius</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q03.1</td>
                        <td data-vertical-align="middle" data-width="666666">Atresia of foramina of Magendie and Luschka</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q03.8</td>
                        <td data-vertical-align="middle" data-width="666666">Other congenital hydrocephalus</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q03.9</td>
                        <td data-vertical-align="middle" data-width="666666">Congenital hydrocephalus, unspecified</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q04.3</td>
                        <td data-vertical-align="middle" data-width="666666">Other reduction deformities of brain</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q04.5</td>
                        <td data-vertical-align="middle" data-width="666666">Megalencephaly</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q04.6</td>
                        <td data-vertical-align="middle" data-width="666666">Congenital cerebral cysts</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q04.8</td>
                        <td data-vertical-align="middle" data-width="666666">Other specified congenital malformations of brain</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q05.0</td>
                        <td data-vertical-align="middle" data-width="666666">Cervical spina bifida with hydrocephalus</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q05.1</td>
                        <td data-vertical-align="middle" data-width="666666">Thoracic spina bifida with hydrocephalus</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q05.2</td>
                        <td data-vertical-align="middle" data-width="666666">Lumbar spina bifida with hydrocephalus</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q05.3</td>
                        <td data-vertical-align="middle" data-width="666666">Sacral spina bifida with hydrocephalus</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q05.4</td>
                        <td data-vertical-align="middle" data-width="666666">Unspecified spina bifida with hydrocephalus</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q05.5</td>
                        <td data-vertical-align="middle" data-width="666666">Cervical spina bifida without hydrocephalus</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q05.6</td>
                        <td data-vertical-align="middle" data-width="666666">Thoracic spina bifida without hydrocephalus</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q05.7</td>
                        <td data-vertical-align="middle" data-width="666666">Lumbar spina bifida without hydrocephalus</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q05.8</td>
                        <td data-vertical-align="middle" data-width="666666">Sacral spina bifida without hydrocephalus</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q05.9</td>
                        <td data-vertical-align="middle" data-width="666666">Spina bifida, unspecified</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q06.0</td>
                        <td data-vertical-align="middle" data-width="666666">Amyelia</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q06.1</td>
                        <td data-vertical-align="middle" data-width="666666">Hypoplasia and dysplasia of spinal cord</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q06.2</td>
                        <td data-vertical-align="middle" data-width="666666">Diastematomyelia</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q06.3</td>
                        <td data-vertical-align="middle" data-width="666666">Other congenital cauda equina malformations</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q06.4</td>
                        <td data-vertical-align="middle" data-width="666666">Hydromyelia</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q06.8</td>
                        <td data-vertical-align="middle" data-width="666666">Other specified congenital malformations of spinal cord</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q07.01</td>
                        <td data-vertical-align="middle" data-width="666666">Arnold-Chiari syndrome with spina bifida</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q07.02</td>
                        <td data-vertical-align="middle" data-width="666666">Arnold-Chiari syndrome with hydrocephalus</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q07.03</td>
                        <td data-vertical-align="middle" data-width="666666">Arnold-Chiari syndrome with spina bifida and hydrocephalus</td>
                        <td data-text-align="center" data-width="166666">0—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q30.1</td>
                        <td data-vertical-align="middle" data-width="666666">Agenesis and underdevelopment of nose, cleft or absent nose only</td>
                        <td data-text-align="center" data-width="166666">0—5</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q30.2</td>
                        <td data-vertical-align="middle" data-width="666666">Fissured, notched and cleft nose, cleft or absent nose only</td>
                        <td data-text-align="center" data-width="166666">0—5</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q31.0</td>
                        <td data-vertical-align="middle" data-width="666666">Web of larynx</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q31.8</td>
                        <td data-vertical-align="middle" data-width="666666">Other congenital malformations of larynx, atresia or agenesis of larynx only</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q32.1</td>
                        <td data-vertical-align="middle" data-width="666666">Other congenital malformations of trachea, atresia or agenesis of trachea only</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q32.4</td>
                        <td data-vertical-align="middle" data-width="666666">Other congenital malformations of bronchus, atresia or agenesis of bronchus only</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q33.0</td>
                        <td data-vertical-align="middle" data-width="666666">Congenital cystic lung</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q33.2</td>
                        <td data-vertical-align="middle" data-width="666666">Sequestration of lung</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q33.3</td>
                        <td data-vertical-align="middle" data-width="666666">Agenesis of lung</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q33.6</td>
                        <td data-vertical-align="middle" data-width="666666">Congenital hypoplasia and dysplasia of lung</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q35.1</td>
                        <td data-vertical-align="middle" data-width="666666">Cleft hard palate</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q35.3</td>
                        <td data-vertical-align="middle" data-width="666666">Cleft soft palate</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q35.5</td>
                        <td data-vertical-align="middle" data-width="666666">Cleft hard palate with cleft soft palate</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q35.9</td>
                        <td data-vertical-align="middle" data-width="666666">Cleft palate, unspecified</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q37.0</td>
                        <td data-vertical-align="middle" data-width="666666">Cleft hard palate with bilateral cleft lip</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q37.1</td>
                        <td data-vertical-align="middle" data-width="666666">Cleft hard palate with unilateral cleft lip</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q37.2</td>
                        <td data-vertical-align="middle" data-width="666666">Cleft soft palate with bilateral cleft lip</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q37.3</td>
                        <td data-vertical-align="middle" data-width="666666">Cleft soft palate with unilateral cleft lip</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q37.4</td>
                        <td data-vertical-align="middle" data-width="666666">Cleft hard and soft palate with bilateral cleft lip</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q37.5</td>
                        <td data-vertical-align="middle" data-width="666666">Cleft hard and soft palate with unilateral cleft lip</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q37.8</td>
                        <td data-vertical-align="middle" data-width="666666">Unspecified cleft palate with bilateral cleft lip</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q37.9</td>
                        <td data-vertical-align="middle" data-width="666666">Unspecified cleft palate with unilateral cleft lip</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q39.0</td>
                        <td data-vertical-align="middle" data-width="666666">Atresia of esophagus without fistula</td>
                        <td data-text-align="center" data-width="166666">0—3</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q39.1</td>
                        <td data-vertical-align="middle" data-width="666666">Atresia of esophagus with tracheo-esophageal fistula</td>
                        <td data-text-align="center" data-width="166666">0—3</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q39.2</td>
                        <td data-vertical-align="middle" data-width="666666">Congenital tracheo-esophageal fistula without atresia</td>
                        <td data-text-align="center" data-width="166666">0—3</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q39.3</td>
                        <td data-vertical-align="middle" data-width="666666">Congenital stenosis and stricture of esophagus</td>
                        <td data-text-align="center" data-width="166666">0—3</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q39.4</td>
                        <td data-vertical-align="middle" data-width="666666">Esophageal web</td>
                        <td data-text-align="center" data-width="166666">0—3</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q42.0</td>
                        <td data-vertical-align="middle" data-width="666666">Congenital absence, atresia and stenosis of rectum with fistula</td>
                        <td data-text-align="center" data-width="166666">0—5</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q42.1</td>
                        <td data-vertical-align="middle" data-width="666666">Congen absence, atresia and stenosis of rectum without fistula</td>
                        <td data-text-align="center" data-width="166666">0—5</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q42.2</td>
                        <td data-vertical-align="middle" data-width="666666">Congenital absence, atresia and stenosis of anus with fistula</td>
                        <td data-text-align="center" data-width="166666">0—5</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q42.3</td>
                        <td data-vertical-align="middle" data-width="666666">Congenital absence, atresia and stenosis of anus without fistula</td>
                        <td data-text-align="center" data-width="166666">0—5</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q42.8</td>
                        <td data-vertical-align="middle" data-width="666666">Congenital absence, atresia and stenosis of other parts of large intestine</td>
                        <td data-text-align="center" data-width="166666">0—5</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q42.9</td>
                        <td data-vertical-align="middle" data-width="666666">Congenital absence, atresia and stenosis of large intestine, part unspecified</td>
                        <td data-text-align="center" data-width="166666">0—5</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q43.1</td>
                        <td data-vertical-align="middle" data-width="666666">Hirschsprung’s disease</td>
                        <td data-text-align="center" data-width="166666">0—15</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q44.2</td>
                        <td data-vertical-align="middle" data-width="666666">Atresia of bile ducts</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q44.3</td>
                        <td data-vertical-align="middle" data-width="666666">Congenital stenosis and stricture of bile ducts</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q44.6</td>
                        <td data-vertical-align="middle" data-width="666666">Cystic disease of liver</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q45.0</td>
                        <td data-vertical-align="middle" data-width="666666">Agenesis, aplasia and hypoplasia of pancreas</td>
                        <td data-text-align="center" data-width="166666">0—5</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q45.1</td>
                        <td data-vertical-align="middle" data-width="666666">Annular pancreas</td>
                        <td data-text-align="center" data-width="166666">0—5</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q45.3</td>
                        <td data-vertical-align="middle" data-width="666666">Other congenital malformations of pancreas and pancreatic duct</td>
                        <td data-text-align="center" data-width="166666">0—5</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q45.8</td>
                        <td data-vertical-align="middle" data-width="666666">Other specified congenital malformations of digestive system</td>
                        <td data-text-align="center" data-width="166666">0—10</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q60.1</td>
                        <td data-vertical-align="middle" data-width="666666">Renal agenesis, bilateral</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q60.4</td>
                        <td data-vertical-align="middle" data-width="666666">Renal hypoplasia, bilateral</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q60.6</td>
                        <td data-vertical-align="middle" data-width="666666">Potter’s syndrome, with bilateral renal agenesis only</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q61.02</td>
                        <td data-vertical-align="middle" data-width="666666">Congenital multiple renal cysts, bilateral only</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q61.19</td>
                        <td data-vertical-align="middle" data-width="666666">Other polycystic kidney, infantile type, bilateral only</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q61.2</td>
                        <td data-vertical-align="middle" data-width="666666">Polycystic kidney, adult type, bilateral only</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q61.3</td>
                        <td data-vertical-align="middle" data-width="666666">Polycystic kidney, unspecified, bilateral only</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q61.4</td>
                        <td data-vertical-align="middle" data-width="666666">Renal dysplasia, bilateral only</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q61.5</td>
                        <td data-vertical-align="middle" data-width="666666">Medullary cystic kidney, bilateral only</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q61.9</td>
                        <td data-vertical-align="middle" data-width="666666">Cystic kidney disease, unspecified, bilateral only</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q64.10</td>
                        <td data-vertical-align="middle" data-width="666666">Exstrophy of urinary bladder, unspecified</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q64.12</td>
                        <td data-vertical-align="middle" data-width="666666">Cloacal extrophy of urinary bladder</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q64.19</td>
                        <td data-vertical-align="middle" data-width="666666">Other exstrophy of urinary bladder</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q75.0</td>
                        <td data-vertical-align="middle" data-width="666666">Craniosynostosis</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q75.1</td>
                        <td data-vertical-align="middle" data-width="666666">Craniofacial dysostosis</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q75.2</td>
                        <td data-vertical-align="middle" data-width="666666">Hypertelorism</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q75.4</td>
                        <td data-vertical-align="middle" data-width="666666">Mandibulofacial dysostosis</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q75.5</td>
                        <td data-vertical-align="middle" data-width="666666">Oculomandibular dysostosis</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q75.8</td>
                        <td data-vertical-align="middle" data-width="666666">Other congenital malformations of skull and face bones</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q77.4</td>
                        <td data-vertical-align="middle" data-width="666666">Achondroplasia</td>
                        <td data-text-align="center" data-width="166666">0—1</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q77.6</td>
                        <td data-vertical-align="middle" data-width="666666">Chondroectodermal dysplasia</td>
                        <td data-text-align="center" data-width="166666">0—1</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q77.8</td>
                        <td data-vertical-align="middle" data-width="666666">Other osteochondrodysplasia with defects of growth of tubular bones and spine</td>
                        <td data-text-align="center" data-width="166666">0—1</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q78.0</td>
                        <td data-vertical-align="middle" data-width="666666">Osteogenesis imperfecta</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q78.1</td>
                        <td data-vertical-align="middle" data-width="666666">Polyostotic fibrous dysplasia</td>
                        <td data-text-align="center" data-width="166666">0—1</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q78.2</td>
                        <td data-vertical-align="middle" data-width="666666">Osteopetrosis</td>
                        <td data-text-align="center" data-width="166666">0—1</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q78.3</td>
                        <td data-vertical-align="middle" data-width="666666">Progressive diaphyseal dysplasia</td>
                        <td data-text-align="center" data-width="166666">0—1</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q78.4</td>
                        <td data-vertical-align="middle" data-width="666666">Enchondromatosis</td>
                        <td data-text-align="center" data-width="166666">0—1</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q78.6</td>
                        <td data-vertical-align="middle" data-width="666666">Multiple congenital exostoses</td>
                        <td data-text-align="center" data-width="166666">0—1</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q78.8</td>
                        <td data-vertical-align="middle" data-width="666666">Other specified osteochondrodysplasias</td>
                        <td data-text-align="center" data-width="166666">0—1</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q78.9</td>
                        <td data-vertical-align="middle" data-width="666666">Osteochondrodysplasia, unspecified</td>
                        <td data-text-align="center" data-width="166666">0—1</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q79.0</td>
                        <td data-vertical-align="middle" data-width="666666">Congenital diaphragmatic hernia</td>
                        <td data-text-align="center" data-width="166666">0—1</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q79.1</td>
                        <td data-vertical-align="middle" data-width="666666">Other congenital malformations of diaphragm</td>
                        <td data-text-align="center" data-width="166666">0—1</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q79.2</td>
                        <td data-vertical-align="middle" data-width="666666">Exomphalos</td>
                        <td data-text-align="center" data-width="166666">0—1</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q79.3</td>
                        <td data-vertical-align="middle" data-width="666666">Gastroschisis</td>
                        <td data-text-align="center" data-width="166666">0—1</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q79.4</td>
                        <td data-vertical-align="middle" data-width="666666">Prune belly syndrome</td>
                        <td data-text-align="center" data-width="166666">0—1</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q79.59</td>
                        <td data-vertical-align="middle" data-width="666666">Other congenital malformations of abdominal wall</td>
                        <td data-text-align="center" data-width="166666">0—1</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Q89.7</td>
                        <td data-vertical-align="middle" data-width="666666">Multiple congenital malformations, not elsewhere classified</td>
                        <td data-text-align="center" data-width="166666">0—10</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">R75</td>
                        <td data-vertical-align="middle" data-width="666666">Inconclusive laboratory evidence of HIV</td>
                        <td data-text-align="center" data-width="166666">0—12 months</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Z21</td>
                        <td data-vertical-align="middle" data-width="666666">Asymptomatic human immunodeficiency virus infection status</td>
                        <td data-text-align="center" data-width="166666">0—20</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Z99.11</td>
                        <td data-vertical-align="middle" data-width="666666">Dependence on respirator (ventilator) status</td>
                        <td data-text-align="center" data-width="166666">1—64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle" data-width="166666">Z99.2</td>
                        <td data-vertical-align="middle" data-width="666666">Dependence on renal dialysis</td>
                        <td data-text-align="center" data-width="166666">21—64</td>
                      </tr>
                    </tbody>
                  </table>
                </div>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.09.69.18" data-order="|10|09|69|.18|" data-ref-path="10|09|69|.18" class="h__section">.18 Appeals Procedures.</h2>
                <p>Appeal procedures are as set forth in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.01.04" title="Chapter 04 Fair Hearing Appeals Under the Maryland State Medical Assistance Program">COMAR 10.01.04</a> and <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.36" title="Chapter 36 General Medical Assistance Provider Participation Criteria">10.09.36</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
              </div>
            </article>
          </main>
          <nav id="area__navigation_mini" class="ns__document__maryland-dsd" aria-label="Previous and next article links">
            <section>
              <a href="/us/md/exec/comar/10.09.68" aria-label="Chapter 68 Maryland Medicaid Managed Care Program: Program Integrity [Transferred to COMAR 10.67.07]">
                <div class="h__ui">Previous</div>
                <span>Chapter 68 Maryland Medicaid Managed Care Program: Program Integrity [Transferred to COMAR 10.67.07]</span>
              </a>
            </section>
            <section>
              <a href="/us/md/exec/comar/10.09.70" aria-label="Chapter 70 Maryland Medicaid Managed Care Program: Non-Capitated Covered Services [Transferred to COMAR 10.67.08]">
                <div class="h__ui">Next</div>
                <span>Chapter 70 Maryland Medicaid Managed Care Program: Non-Capitated Covered Services [Transferred to COMAR 10.67.08]</span>
              </a>
            </section>
          </nav>
        </div>
      </div>
      <footer id="section__footer" class="ns__document__maryland-dsd">
        <div id="section__footer__inner" class="ns__document__maryland-dsd">
          <div id="area__footer__content" class="ns__document__maryland-dsd">
<p>This version of the laws and codes on this website is licensed under the <a href="https://creativecommons.org/licenses/by-nc-sa/4.0/">CC BY-NC-SA 4.0</a> license with copyright held by the State of Maryland.</p><p>This version of the laws and codes on this website will be dedicated to the public domain under the <a href="https://creativecommons.org/publicdomain/zero/1.0/">CC0 1.0</a> license 180 days after publication.</p>
<p>
      Please do not scrape. Instead, bulk download the CC BY-NC-SA-4.0 <a href="https://github.com/maryland-dsd/law-html">HTML</a> or <a href="https://github.com/maryland-dsd/law-xml">XML</a> or CC0 <a href="https://github.com/maryland-dsd/law-html-cc0">HTML</a> or <a href="https://github.com/maryland-dsd/law-xml-cc0">XML</a>.
    </p><p>Powered by the non-profit <a href="https://www.openlawlib.org/">Open Law Library</a>.</p></div>
        </div>
      </footer>
    </div>
    <!--Piwik analytics-->
    <noscript>
      <img src="/_analytics/pixel.png" style="border:0;" alt=""/>
    </noscript>
  </body>
</html>
